Multiple	O
signals	O
required	O
for	O
cyclic	B-protein
AMP-responsive	I-protein
element	I-protein
binding	I-protein
protein	I-protein
(	O
CREB	B-protein
)	O
binding	O
protein	O
interaction	O
induced	O
by	O
CD3/CD28	O
costimulation	O
.	O

The	O
optimal	O
activation	O
of	O
cAMP-responsive	B-protein
element	I-protein
binding	I-protein
protein	I-protein
(	O
CREB	B-protein
)	O
,	O
similar	O
to	O
the	O
full	O
activation	O
of	O
T	B-cell_type
lymphocytes	I-cell_type
,	O
requires	O
the	O
stimulation	O
of	O
both	O
CD3	B-protein
and	O
CD28	B-protein
.	O

Using	O
a	O
reporter	O
system	O
to	O
detect	O
interaction	O
of	O
CREB	B-protein
and	O
CREB-binding	B-protein
protein	I-protein
(	O
CBP	B-protein
)	O
,	O
in	O
this	O
study	O
we	O
found	O
that	O
CREB	B-protein
binds	O
to	O
CBP	B-protein
only	O
by	O
engagement	O
of	O
both	O
CD3	B-protein
and	O
CD28	B-protein
.	O

CD3/CD28	B-protein
-promoted	O
CREB	B-protein
-	O
CBP	B-protein
interaction	O
was	O
dependent	O
on	O
p38	B-protein
mitogen-activated	I-protein
protein	I-protein
kinase	I-protein
(	O
MAPK	B-protein
)	O
and	O
calcium/calmodulin-dependent	B-protein
protein	I-protein
kinase	I-protein
(	I-protein
CaMK	I-protein
)	I-protein
IV	I-protein
in	O
addition	O
to	O
the	O
previously	O
identified	O
extracellular	O
signal-regulated	O
kinase	O
pathway	O
.	O

Extracellular	B-protein
signal-regulated	I-protein
kinase	I-protein
,	I-protein
CaMKIV	I-protein
,	O
and	O
p38	B-protein
MAPK	I-protein
were	O
also	O
the	O
kinases	O
involved	O
in	O
CREB	B-protein
Ser	O
(	O
133	O
)	O
phosphorylation	O
induced	O
by	O
CD3/CD28	B-protein
.	O

A	O
reconstitution	O
experiment	O
illustrated	O
that	O
optimum	O
CREB	B-protein
-	O
CBP	B-protein
interaction	O
and	O
CREB	B-protein
trans-activation	O
were	O
attained	O
when	O
these	O
three	O
kinase	O
pathways	O
were	O
simultaneously	O
activated	O
in	O
T	B-cell_type
cells	I-cell_type
.	O

Our	O
results	O
demonstrate	O
that	O
coordinated	O
activation	O
of	O
different	O
kinases	B-protein
leads	O
to	O
full	O
activation	O
of	O
CREB	B-protein
.	O

Notably	O
,	O
CD28	O
ligation	O
activated	O
p38	B-protein
MAPK	I-protein
and	O
CaMKIV	B-protein
,	O
the	O
kinases	B-protein
stimulated	O
by	O
CD3	O
engagement	O
,	O
suggesting	O
that	O
CD28	B-protein
acts	O
by	O
increasing	O
the	O
activation	O
extent	O
of	O
p38	B-protein
MAPK	I-protein
and	O
CaMKIV	B-protein
.	O

These	O
results	O
support	O
the	O
model	O
of	O
a	O
minimum	O
activation	O
threshold	O
for	O
CREB	B-protein
-	O
CBP	B-protein
interaction	O
that	O
can	O
be	O
reached	O
only	O
when	O
both	O
CD3	B-protein
and	O
CD28	B-protein
are	O
stimulated	O
.	O

``	NULL
Flexible	NULL
,	NULL
Intuitive	NULL
,	NULL
and	NULL
Luminex	NULL
.	NULL

C4	NULL
-	NULL
«	NULL
gf\	NULL
_	NULL
}	NULL
Affordable	NULL
Cytometry	NULL
,	NULL
warmmore	NULL
complexity	NULL
simplified	NULL
.	NULL

Guava®	NULL
easyCyte	NULL
``	NULL
Flow	NULL
Cytometers	NULL
.	NULL

Ln	NULL
mJournal	NULL
f	NULL
Multiple	NULL
Signals	NULL
Required	NULL
for	NULL
Cyclic	NULL
...	NULL
<	NULL
>	NULL
``	NULL
``	NULL
'Immun010	NULL
gy	NULL
AMP-Responsive	NULL
Element	NULL
Binding	NULL
Protein	NULL
(	NULL
CREB	NULL
)	NULL
Binding	NULL
Protein	NULL
Interaction	NULL
Induced	NULL
by	NULL
CD3/CD28	NULL
Costimulation	NULL
This	NULL
information	NULL
is	NULL
current	NULL
as	NULL
of	NULL
May	NULL
10	NULL
,	NULL
2019	NULL
.	NULL

Cheng-Tai	NULL
Yu	NULL
,	NULL
Hsiu-ming	NULL
Shih	NULL
and	NULL
Ming-Zong	NULL
Lai	NULL
J	NULL
Immunol	NULL
2001	NULL
;	NULL
166:284-292	NULL
;	NULL
;	NULL
doi	NULL
:	NULL
10.4049/jimmunol.166.1.284	NULL
http	NULL
:	NULL
//www	NULL
.jimmunol.org/content/166/1/284	NULL
References	NULL
_	NULL
This	NULL
article	NULL
cites	NULL
70	NULL
articles	NULL
,	NULL
44	NULL
of	NULL
which	NULL
you	NULL
can	NULL
access	NULL
for	NULL
free	NULL
at	NULL
:	NULL
http	NULL
:	NULL
//www	NULL
.jimmunol.org/content/166/1/284.full	NULL
#	NULL
ref-list-1	NULL
Why	NULL
The	NULL
JT	NULL
?	NULL

Submit	NULL
online	NULL
.	NULL

«	NULL
Rapid	NULL
Reviews	NULL
!	NULL

30	NULL
days*	NULL
from	NULL
submission	NULL
to	NULL
initial	NULL
decision	NULL
*	NULL
No	NULL
Triage	NULL
!	NULL

Every	NULL
submission	NULL
reviewed	NULL
by	NULL
practicing	NULL
scientists	NULL
*	NULL
Fast	NULL
Publication	NULL
!	NULL

4	NULL
weeks	NULL
from	NULL
acceptance	NULL
to	NULL
publication	NULL
*average	NULL
Subscription	NULL
_-	NULL
Information	NULL
about	NULL
subscribing	NULL
to	NULL
The	NULL
Journal	NULL
of	NULL
Immunology	NULL
is	NULL
online	NULL
at	NULL
:	NULL
http	NULL
:	NULL
//jimmunol.org/subscription	NULL
Permissions	NULL
_	NULL
Submit	NULL
copyright	NULL
permission	NULL
requests	NULL
at	NULL
:	NULL
http	NULL
:	NULL
//www.aai.org/About/Publications/Jl/copyright.html	NULL
Email	NULL
Alerts	NULL
_	NULL
Receive	NULL
free	NULL
email-alerts	NULL
when	NULL
new	NULL
articles	NULL
cite	NULL
this	NULL
article	NULL
.	NULL

Sign	NULL
up	NULL
at	NULL
:	NULL
http	NULL
:	NULL
//jimmunol.org/alerts	NULL
The	NULL
Journal	NULL
of	NULL
Immunology	NULL
is	NULL
published	NULL
twice	NULL
each	NULL
month	NULL
by	NULL
The	NULL
American	NULL
Association	NULL
of	NULL
Immunologists	NULL
,	NULL
Inc.	NULL
,	NULL
1451	NULL
Rockville	NULL
Pike	NULL
,	NULL
Suite	NULL
650	NULL
,	NULL
Rockville	NULL
,	NULL
MD	NULL
20852	NULL
Copyright	NULL
©	NULL
2001	NULL
by	NULL
The	NULL
American	NULL
Association	NULL
of	NULL
Immunologists	NULL
All	NULL
rights	NULL
reserved	NULL
.	NULL

Print	NULL
ISSN	NULL
:	NULL
0022-1767	NULL
Online	NULL
ISSN	NULL
:	NULL
1550-6606	NULL
.	NULL

6107	NULL
'0t	NULL
4epy	NULL
uo	NULL
1san8	NULL
4q	NULL
[	NULL
810	NULL
fountwrut	NULL
[	NULL
'mmmy	NULL
;	NULL
/	NULL
:	NULL
dyy	NULL
wor	NULL
Multiple	NULL
Signals	NULL
Required	NULL
for	NULL
Cyclic	NULL
AMP-Responsive	NULL
Element	NULL
Binding	NULL
Protein	NULL
(	NULL
CREB	NULL
)	NULL
Binding	NULL
Protein	NULL
Interaction	NULL
Induced	NULL
by	NULL
CD3/CD28	NULL
Costimulation	NULL
'	NULL
Cheng-Tai	NULL
Yu	NULL
,	NULL
*	NULL
``	NULL
Hsiu-ming	NULL
Shih	NULL
,	NULL
*	NULL
and	NULL
Ming-Zong	NULL
Lai	NULL
``	NULL
*	NULL
'	NULL
``	NULL
``	NULL
The	NULL
optimal	NULL
activation	NULL
of	NULL
cAMP-responsive	NULL
element	NULL
binding	NULL
protein	NULL
(	NULL
CREB	NULL
)	NULL
,	NULL
similar	NULL
to	NULL
the	NULL
full	NULL
activation	NULL
of	NULL
T	NULL
lymphocytes	NULL
,	NULL
requires	NULL
the	NULL
stimulation	NULL
of	NULL
both	NULL
CD3	NULL
and	NULL
CD28	NULL
.	NULL

Using	NULL
a	NULL
reporter	NULL
system	NULL
to	NULL
detect	NULL
interaction	NULL
of	NULL
CREB	NULL
and	NULL
CREB-binding	NULL
protein	NULL
(	NULL
CBP	NULL
)	NULL
,	NULL
in	NULL
this	NULL
study	NULL
we	NULL
found	NULL
that	NULL
CREB	NULL
binds	NULL
to	NULL
CBP	NULL
only	NULL
by	NULL
engagement	NULL
of	NULL
both	NULL
CD3	NULL
and	NULL
CD28	NULL
.	NULL

CD3/CD28-promoted	NULL
CREB-CBP	NULL
interaction	NULL
was	NULL
dependent	NULL
on	NULL
p38	NULL
mitogen-activated	NULL
protein	NULL
kinase	NULL
(	NULL
MAPK	NULL
)	NULL
and	NULL
calcium/calmodulin-dependent	NULL
protein	NULL
kinase	NULL
(	NULL
CaMK	NULL
)	NULL
IV	NULL
in	NULL
addition	NULL
to	NULL
the	NULL
previously	NULL
identified	NULL
extracellular	NULL
signal-regulated	NULL
kinase	NULL
pathway	NULL
.	NULL

Extracellular	NULL
signal-regulated	NULL
kinase	NULL
,	NULL
CaMKIV	NULL
,	NULL
and	NULL
p38	NULL
MAPK	NULL
were	NULL
also	NULL
the	NULL
kinases	NULL
involved	NULL
in	NULL
CREB	NULL
Ser'*	NULL
>	NULL
phosphorylation	NULL
induced	NULL
by	NULL
CD3/CD28	NULL
.	NULL

A	NULL
reconstitution	NULL
experiment	NULL
illustrated	NULL
that	NULL
optimum	NULL
CREB-CBP	NULL
interaction	NULL
and	NULL
CREB	NULL
frans-activation	NULL
were	NULL
attained	NULL
when	NULL
these	NULL
three	NULL
kinase	NULL
pathways	NULL
were	NULL
simultaneously	NULL
activated	NULL
in	NULL
T	NULL
cells	NULL
.	NULL

Our	NULL
results	NULL
demonstrate	NULL
that	NULL
coordinated	NULL
activation	NULL
of	NULL
different	NULL
kinases	NULL
leads	NULL
to	NULL
full	NULL
activation	NULL
of	NULL
CREB	NULL
.	NULL

Notably	NULL
,	NULL
CD28	NULL
ligation	NULL
activated	NULL
p38	NULL
MAPK	NULL
and	NULL
CaMKIV	NULL
,	NULL
the	NULL
kinases	NULL
stimulated	NULL
by	NULL
CD3	NULL
engagement	NULL
,	NULL
suggesting	NULL
that	NULL
CD28	NULL
acts	NULL
by	NULL
increasing	NULL
the	NULL
activation	NULL
extent	NULL
of	NULL
p38	NULL
MAPK	NULL
and	NULL
CaMKIV	NULL
.	NULL

These	NULL
results	NULL
support	NULL
the	NULL
model	NULL
of	NULL
a	NULL
minimum	NULL
activation	NULL
threshold	NULL
for	NULL
CREB-CBP	NULL
interaction	NULL
that	NULL
can	NULL
be	NULL
reached	NULL
only	NULL
when	NULL
both	NULL
CD3	NULL
and	NULL
CD28	NULL
are	NULL
stimulated	NULL
.	NULL

The	NULL
Journal	NULL
of	NULL
Immunology	NULL
,	NULL
2001	NULL
,	NULL
166	NULL
:	NULL
284-292.	NULL
yelic	NULL
AMP	NULL
-responsive	NULL
element	NULL
binding	NULL
protein	NULL
(	NULL
CREB	NULL
)	NULL
mediates	NULL
cAMP-responsive	NULL
gene	NULL
expression	NULL
in	NULL
a	NULL
well-characterized	NULL
scheme	NULL
(	NULL
1-3	NULL
)	NULL
.	NULL

CREB	NULL
binds	NULL
to	NULL
the	NULL
cAMP-responsive	NULL
element	NULL
(	NULL
CRE	NULL
)	NULL
located	NULL
in	NULL
the	NULL
promoter	NULL
of	NULL
most	NULL
cAMP-inducible	NULL
genes	NULL
(	NULL
4	NULL
,	NULL
5	NULL
)	NULL
.	NULL

The	NULL
phosphorylation	NULL
of	NULL
CREB	NULL
Ser'*	NULL
>	NULL
by	NULL
protein	NULL
kinase	NULL
A	NULL
(	NULL
6	NULL
,	NULL
7	NULL
)	NULL
promotes	NULL
the	NULL
binding	NULL
of	NULL
the	NULL
kinase-induc-ible	NULL
domain	NULL
of	NULL
CREB	NULL
to	NULL
the	NULL
KIX	NULL
domain	NULL
of	NULL
CREB	NULL
binding	NULL
protein	NULL
(	NULL
CBP	NULL
)	NULL
through	NULL
electrostatic	NULL
interaction	NULL
(	NULL
8-11	NULL
)	NULL
.	NULL

CBP	NULL
then	NULL
initiates	NULL
the	NULL
transcription	NULL
of	NULL
CRE-containing	NULL
genes	NULL
by	NULL
the	NULL
associated	NULL
RNA	NULL
polymerase	NULL
II	NULL
and	NULL
histone	NULL
acetyl	NULL
transferase	NULL
activities	NULL
(	NULL
9	NULL
,	NULL
12	NULL
)	NULL
.	NULL

Ser'*	NULL
>	NULL
phosphorylation	NULL
hence	NULL
plays	NULL
a	NULL
critical	NULL
role	NULL
in	NULL
CREB	NULL
activation	NULL
.	NULL

Mutation	NULL
of	NULL
serine	NULL
to	NULL
alanine	NULL
at	NULL
position	NULL
133	NULL
converts	NULL
CREB	NULL
into	NULL
a	NULL
dominant	NULL
negative	NULL
transcriptional	NULL
regulator	NULL
.	NULL

In	NULL
addition	NULL
to	NULL
cAMP	NULL
,	NULL
CREB	NULL
is	NULL
activated	NULL
by	NULL
Ca**	NULL
,	NULL
growth	NULL
fac-tors	NULL
,	NULL
and	NULL
stress	NULL
signals	NULL
(	NULL
1-3	NULL
)	NULL
.	NULL

A	NULL
number	NULL
of	NULL
different	NULL
kinases	NULL
have	NULL
been	NULL
shown	NULL
to	NULL
stimulate	NULL
CREB	NULL
phosphorylation	NULL
and	NULL
several	NULL
*Graduate	NULL
Institute	NULL
of	NULL
Life	NULL
Science	NULL
,	NULL
National	NULL
Defense	NULL
Medical	NULL
School	NULL
;	NULL
*Institute	NULL
of	NULL
Molecular	NULL
Biology	NULL
,	NULL
Academia	NULL
Sinica	NULL
;	NULL
*Division	NULL
of	NULL
Molecular	NULL
and	NULL
Genomic	NULL
Medi-cine	NULL
,	NULL
National	NULL
Health	NULL
Research	NULL
Institute	NULL
;	NULL
Graduate	NULL
Institute	NULL
of	NULL
Immunology	NULL
,	NULL
National	NULL
Taiwan	NULL
University	NULL
;	NULL
and	NULL
``	NULL
Graduate	NULL
Institute	NULL
of	NULL
Microbiology	NULL
and	NULL
Immunology	NULL
,	NULL
National	NULL
Yang-Ming	NULL
University	NULL
,	NULL
Taipei	NULL
,	NULL
Taiwan	NULL
,	NULL
Republic	NULL
of	NULL
China	NULL
Received	NULL
for	NULL
publication	NULL
July	NULL
21	NULL
,	NULL
2000	NULL
.	NULL

Accepted	NULL
for	NULL
publication	NULL
October	NULL
,	NULL
10	NULL
,	NULL
2000	NULL
.	NULL

The	NULL
costs	NULL
of	NULL
publication	NULL
of	NULL
this	NULL
article	NULL
were	NULL
defrayed	NULL
in	NULL
part	NULL
by	NULL
the	NULL
payment	NULL
of	NULL
page	NULL
charges	NULL
.	NULL

This	NULL
article	NULL
must	NULL
therefore	NULL
be	NULL
hereby	NULL
marked	NULL
adverfisement	NULL
in	NULL
accordance	NULL
with	NULL
18	NULL
U.S.C	NULL
.	NULL

Section	NULL
1734	NULL
solely	NULL
to	NULL
indicate	NULL
this	NULL
fact	NULL
.	NULL

*	NULL
This	NULL
work	NULL
was	NULL
supported	NULL
by	NULL
Grant	NULL
89-2311-B001-109	NULL
from	NULL
the	NULL
National	NULL
Science	NULL
Council	NULL
and	NULL
a	NULL
grant	NULL
from	NULL
Academia	NULL
Sinica	NULL
,	NULL
Taiwan	NULL
,	NULL
Republic	NULL
of	NULL
China	NULL
.	NULL

?	NULL

Address	NULL
correspondence	NULL
and	NULL
reprint	NULL
requests	NULL
to	NULL
Dr.	NULL
Ming-Zong	NULL
Lai	NULL
,	NULL
Institute	NULL
of	NULL
Molecular	NULL
Biology	NULL
,	NULL
Academia	NULL
Sinica	NULL
,	NULL
Nankang	NULL
,	NULL
Taipei	NULL
11529	NULL
,	NULL
Taiwan	NULL
,	NULL
Republic	NULL
of	NULL
China	NULL
.	NULL

E-mail	NULL
address	NULL
:	NULL
mblai	NULL
@	NULL
ccvax.sinica.edu.tw	NULL
3	NULL
Abbreviations	NULL
used	NULL
in	NULL
this	NULL
paper	NULL
:	NULL
CREB	NULL
,	NULL
cAMP-responsive	NULL
element	NULL
binding	NULL
protein	NULL
;	NULL
CaMK	NULL
,	NULL
calcium/calmodulin-dependent	NULL
protein	NULL
kinase	NULL
;	NULL
CAT	NULL
,	NULL
chloramphenicol	NULL
acetyl-transferase	NULL
;	NULL
CRE	NULL
,	NULL
cAMP-responsive	NULL
element	NULL
;	NULL
CBP	NULL
,	NULL
CREB	NULL
binding	NULL
protein	NULL
;	NULL
CBD	NULL
,	NULL
CREB-binding	NULL
domain	NULL
of	NULL
CBP	NULL
;	NULL
ERK	NULL
,	NULL
extracellular	NULL
signal-regulated	NULL
kinase	NULL
;	NULL
JNK	NULL
,	NULL
c-Jun	NULL
N-terminal	NULL
kinase	NULL
;	NULL
MAPK	NULL
,	NULL
mitogen-activated	NULL
protein	NULL
kinase	NULL
;	NULL
MKK	NULL
,	NULL
MAPK	NULL
kinase	NULL
;	NULL
PCNA	NULL
,	NULL
proliferating	NULL
cell	NULL
nuclear	NULL
Ag	NULL
;	NULL
PI	NULL
3-kinase	NULL
,	NULL
phosphatidylinositol	NULL
3-ki-nase	NULL
;	NULL
RSK	NULL
,	NULL
ribosomal	NULL
S6	NULL
kinase	NULL
;	NULL
STBS	NULL
,	NULL
25	NULL
mM	NULL
Tris-HCI	NULL
(	NULL
pH	NULL
7.4	NULL
)	NULL
,	NULL
137	NULL
mM	NULL
NaCl	NULL
,	NULL
5	NULL
mM	NULL
KCI	NULL
,	NULL
0.6	NULL
mM	NULL
Na	NULL
,	NULL
HPO	NULL
,	NULL
,	NULL
0.7	NULL
mM	NULL
CaCl	NULL
,	NULL
,	NULL
and	NULL
0.5	NULL
mM	NULL
MgCl	NULL
,	NULL
,	NULL
.	NULL

Copyright	NULL
©	NULL
2001	NULL
by	NULL
The	NULL
American	NULL
Association	NULL
of	NULL
Immunologists	NULL
CREB	NULL
kinase	NULL
candidates	NULL
have	NULL
been	NULL
identified	NULL
.	NULL

The	NULL
calcium	NULL
signaling	NULL
that	NULL
activates	NULL
CREB	NULL
can	NULL
be	NULL
traced	NULL
back	NULL
to	NULL
calcium/calmodulin-dependent	NULL
protein	NULL
kinase	NULL
I	NULL
(	NULL
CaMKI	NULL
)	NULL
,	NULL
CaMKII	NULL
,	NULL
and	NULL
CaMKIV	NULL
,	NULL
which	NULL
are	NULL
activated	NULL
by	NULL
the	NULL
increase	NULL
in	NULL
the	NULL
calcium/calmodulin	NULL
complex	NULL
.	NULL

Even	NULL
though	NULL
CaMKI	NULL
and	NULL
CaMKII	NULL
phosphorylate	NULL
CREB	NULL
in	NULL
vitro	NULL
,	NULL
CaMKI	NULL
is	NULL
not	NULL
translocated	NULL
into	NULL
the	NULL
nucleus	NULL
,	NULL
and	NULL
CaMKII	NULL
does	NULL
not	NULL
activate	NULL
CREB	NULL
transcriptionally	NULL
(	NULL
13-15	NULL
)	NULL
.	NULL

CaMKIV	NULL
is	NULL
thus	NULL
the	NULL
kinase	NULL
that	NULL
mediates	NULL
calcium-induced	NULL
CREB	NULL
phosphorylation	NULL
in	NULL
vivo	NULL
.	NULL

In	NULL
the	NULL
other	NULL
major	NULL
pathway	NULL
involved	NULL
in	NULL
CREB	NULL
activation	NULL
,	NULL
the	NULL
mitogen-activated	NULL
protein	NULL
kinase	NULL
(	NULL
MAPK	NULL
)	NULL
kinase	NULL
(	NULL
MAPKK	NULL
)	NULL
-extracellular	NULL
signal-regulated	NULL
kinase	NULL
(	NULL
ERK	NULL
)	NULL
cascade	NULL
,	NULL
the	NULL
downstream	NULL
p90	NULL
``	NULL
phosphorylates	NULL
CREB	NULL
(	NULL
16	NULL
)	NULL
.	NULL

Other	NULL
ribosomal	NULL
S6	NULL
kinase	NULL
(	NULL
RSK	NULL
)	NULL
family	NULL
members	NULL
,	NULL
RSK1	NULL
and	NULL
RSK3	NULL
,	NULL
also	NULL
phosphorylate	NULL
CREB	NULL
(	NULL
17	NULL
)	NULL
.	NULL

Along	NULL
the	NULL
p38	NULL
MAPK	NULL
cascade	NULL
,	NULL
which	NULL
is	NULL
the	NULL
third	NULL
major	NULL
signaling	NULL
pathway	NULL
that	NULL
contributes	NULL
to	NULL
CREB	NULL
activation	NULL
,	NULL
MAPK-activated	NULL
protein	NULL
kinase	NULL
2	NULL
mediates	NULL
stress-	NULL
and	NULL
fibroblast	NULL
growth	NULL
factor-induced	NULL
phosphorylation	NULL
of	NULL
CREB	NULL
(	NULL
18	NULL
)	NULL
.	NULL

CREB	NULL
is	NULL
also	NULL
directly	NULL
phosphorylated	NULL
by	NULL
mitogen-	NULL
and	NULL
stress-activated	NULL
kinase	NULL
1	NULL
(	NULL
19	NULL
)	NULL
,	NULL
the	NULL
kinase	NULL
activated	NULL
by	NULL
stress	NULL
stimuli	NULL
in	NULL
the	NULL
p38	NULL
MAPK-dependent	NULL
pathway	NULL
or	NULL
by	NULL
growth	NULL
factor	NULL
in	NULL
the	NULL
ERK-de-pendent	NULL
cascade	NULL
.	NULL

A	NULL
third	NULL
CREB	NULL
kinase	NULL
controlled	NULL
by	NULL
p38/SAPK2	NULL
,	NULL
RSK-B	NULL
,	NULL
has	NULL
been	NULL
identified	NULL
(	NULL
20	NULL
)	NULL
.	NULL

In	NULL
addition	NULL
to	NULL
the	NULL
calcium	NULL
,	NULL
ERK	NULL
,	NULL
and	NULL
p38	NULL
signal	NULL
pathways	NULL
,	NULL
CREB	NULL
is	NULL
phosphorylated	NULL
by	NULL
Akt	NULL
(	NULL
21	NULL
)	NULL
.	NULL

The	NULL
CREB	NULL
analogue	NULL
CREM	NULL
can	NULL
also	NULL
be	NULL
phosphorylated	NULL
by	NULL
PKC	NULL
and	NULL
p70	NULL
S6	NULL
kinase	NULL
(	NULL
22	NULL
,	NULL
23	NULL
)	NULL
.	NULL

The	NULL
presence	NULL
of	NULL
a	NULL
large	NULL
number	NULL
of	NULL
CREB	NULL
kinases	NULL
indicates	NULL
that	NULL
phosphorylation	NULL
of	NULL
CREB	NULL
may	NULL
be	NULL
mediated	NULL
by	NULL
two	NULL
or	NULL
more	NULL
kinases	NULL
under	NULL
the	NULL
same	NULL
stimulus	NULL
.	NULL

For	NULL
example	NULL
,	NULL
nerve	NULL
growth	NULL
factor-induced	NULL
CREB	NULL
phosphorylation	NULL
involves	NULL
both	NULL
RSK	NULL
and	NULL
MAPK-activated	NULL
protein	NULL
kinase	NULL
(	NULL
17	NULL
)	NULL
.	NULL

TCR	NULL
engagement	NULL
leads	NULL
to	NULL
CREB	NULL
phosphorylation	NULL
(	NULL
24	NULL
,	NULL
25	NULL
)	NULL
.	NULL

The	NULL
transcriptional	NULL
activation	NULL
of	NULL
CREB	NULL
is	NULL
essential	NULL
for	NULL
T	NULL
cell	NULL
activation	NULL
and	NULL
development	NULL
.	NULL

Blockage	NULL
of	NULL
CREB	NULL
transcriptional	NULL
activation	NULL
by	NULL
T	NULL
cell-specific	NULL
transgenic	NULL
expression	NULL
of	NULL
the	NULL
dominant	NULL
negative	NULL
CREB	NULL
or	NULL
dominant	NULL
negative	NULL
CaMKIV	NULL
greatly	NULL
impairs	NULL
thymocyte	NULL
proliferation	NULL
and	NULL
IL-2	NULL
production	NULL
(	NULL
26	NULL
,	NULL
27	NULL
)	NULL
.	NULL

Moreover	NULL
,	NULL
genetic	NULL
knockout	NULL
of	NULL
CREB	NULL
abolishes	NULL
«	NULL
f	NULL
T	NULL
cell	NULL
development	NULL
in	NULL
mice	NULL
(	NULL
28	NULL
)	NULL
.	NULL

0022-1767/01/	NULL
$	NULL
02.00	NULL
6107	NULL
'0t	NULL
4epy	NULL
uo	NULL
1san8	NULL
4q	NULL
[	NULL
810	NULL
fountwrut	NULL
[	NULL
'mmmy	NULL
;	NULL
/	NULL
:	NULL
dyy	NULL
wor	NULL
The	NULL
Journal	NULL
of	NULL
Immunology	NULL
CREB	NULL
is	NULL
required	NULL
for	NULL
the	NULL
expression	NULL
of	NULL
proliferating	NULL
cell	NULL
nuclear	NULL
Ag	NULL
(	NULL
PCNA	NULL
)	NULL
which	NULL
contributes	NULL
to	NULL
cell	NULL
cycle	NULL
progression	NULL
(	NULL
29	NULL
)	NULL
.	NULL

CREB	NULL
may	NULL
also	NULL
participate	NULL
in	NULL
Th	NULL
cell	NULL
development	NULL
through	NULL
regulated	NULL
expression	NULL
of	NULL
y-IFN	NULL
(	NULL
30	NULL
)	NULL
.	NULL

We	NULL
previously	NULL
illustrated	NULL
that	NULL
full	NULL
CREB	NULL
activation	NULL
,	NULL
similar	NULL
to	NULL
T	NULL
cell	NULL
activation	NULL
,	NULL
requires	NULL
dual	NULL
signals	NULL
from	NULL
CD3	NULL
and	NULL
CD28	NULL
(	NULL
25	NULL
)	NULL
.	NULL

CD28	NULL
is	NULL
a	NULL
T	NULL
cell-specific	NULL
cell	NULL
surface	NULL
molecule	NULL
that	NULL
interacts	NULL
with	NULL
B7	NULL
on	NULL
APCs	NULL
.	NULL

The	NULL
costimulation	NULL
signal	NULL
from	NULL
CD28	NULL
acts	NULL
in	NULL
synergy	NULL
with	NULL
the	NULL
mitogenic	NULL
signal	NULL
from	NULL
TCR	NULL
to	NULL
promote	NULL
cell	NULL
cycle	NULL
progression	NULL
and	NULL
to	NULL
increase	NULL
IL-2	NULL
secretion	NULL
(	NULL
for	NULL
reviews	NULL
,	NULL
see	NULL
Refs	NULL
.	NULL

31	NULL
,	NULL
32	NULL
)	NULL
.	NULL

CD28	NULL
costimulation	NULL
also	NULL
prevents	NULL
induction	NULL
of	NULL
T	NULL
cell	NULL
tolerance	NULL
(	NULL
33	NULL
)	NULL
and	NULL
cell	NULL
death	NULL
(	NULL
34	NULL
)	NULL
.	NULL

Even	NULL
though	NULL
the	NULL
essential	NULL
role	NULL
of	NULL
CD28	NULL
is	NULL
well	NULL
recognized	NULL
,	NULL
the	NULL
CD28-mediated	NULL
costimulatory	NULL
signals	NULL
are	NULL
not	NULL
well	NULL
understood	NULL
.	NULL

CD28-mediated	NULL
signals	NULL
are	NULL
known	NULL
to	NULL
involve	NULL
phosphatidylinositol	NULL
3-kinase	NULL
(	NULL
PI	NULL
3-kinase	NULL
)	NULL
(	NULL
35-37	NULL
)	NULL
,	NULL
but	NULL
PI	NULL
3-kinase	NULL
alone	NULL
can	NULL
not	NULL
account	NULL
for	NULL
all	NULL
CD28-mediated	NULL
costimulatory	NULL
events	NULL
(	NULL
38-40	NULL
)	NULL
.	NULL

CD28	NULL
costimulation	NULL
results	NULL
in	NULL
full	NULL
activation	NULL
of	NULL
c-Jun	NULL
N-terminal	NULL
kinase	NULL
(	NULL
JNK	NULL
)	NULL
(	NULL
41	NULL
)	NULL
,	NULL
yet	NULL
signals	NULL
other	NULL
than	NULL
JNK	NULL
are	NULL
required	NULL
for	NULL
the	NULL
induction	NULL
of	NULL
IL-2	NULL
production	NULL
(	NULL
42	NULL
)	NULL
.	NULL

Additional	NULL
candidates	NULL
of	NULL
CD28	NULL
costimulatory	NULL
signals	NULL
include	NULL
IB	NULL
kinase	NULL
(	NULL
43	NULL
)	NULL
and	NULL
p38	NULL
MAPK	NULL
(	NULL
44-46	NULL
)	NULL
.	NULL

Engagement	NULL
of	NULL
both	NULL
CD3	NULL
and	NULL
CD28	NULL
also	NULL
induces	NULL
PDE7	NULL
,	NULL
which	NULL
decreases	NULL
cAMP	NULL
and	NULL
increases	NULL
T	NULL
cell	NULL
activation	NULL
(	NULL
47	NULL
)	NULL
.	NULL

In	NULL
the	NULL
present	NULL
study	NULL
we	NULL
found	NULL
that	NULL
in	NULL
addition	NULL
to	NULL
ERK	NULL
,	NULL
p38	NULL
MAPK	NULL
and	NULL
CaMKIV	NULL
are	NULL
activated	NULL
by	NULL
CD3/CD28	NULL
.	NULL

ERK	NULL
,	NULL
p38	NULL
MAPK	NULL
,	NULL
and	NULL
CaMKIV	NULL
are	NULL
required	NULL
for	NULL
both	NULL
CREB-CBP	NULL
interaction	NULL
and	NULL
CREB	NULL
frans-activation	NULL
,	NULL
which	NULL
were	NULL
significantly	NULL
compromised	NULL
when	NULL
any	NULL
single	NULL
kinase	NULL
cascade	NULL
was	NULL
inhibited	NULL
.	NULL

Our	NULL
findings	NULL
suggest	NULL
that	NULL
multiple	NULL
signals	NULL
are	NULL
required	NULL
to	NULL
coordinate	NULL
a	NULL
stable	NULL
CREB-CBP	NULL
interaction	NULL
.	NULL

Materials	NULL
and	NULL
Methods	NULL
Reagents	NULL
A23187	NULL
,	NULL
tetradecanoyl	NULL
phorbol	NULL
13-acetate	NULL
,	NULL
Con	NULL
A	NULL
,	NULL
and	NULL
prestained	NULL
m.w	NULL
.	NULL

markers	NULL
(	NULL
SDS-7B	NULL
)	NULL
were	NULL
purchased	NULL
from	NULL
Sigma	NULL
(	NULL
St.	NULL
Louis	NULL
,	NULL
MO	NULL
)	NULL
.	NULL

H89	NULL
was	NULL
obtained	NULL
from	NULL
Seikagaku	NULL
(	NULL
Tokyo	NULL
,	NULL
Japan	NULL
)	NULL
.	NULL

DEAE-dextran	NULL
(	NULL
m.w	NULL
.	NULL

,	NULL
5	NULL
X	NULL
10°	NULL
)	NULL
was	NULL
purchased	NULL
from	NULL
Pharmacia	NULL
(	NULL
Uppsala	NULL
,	NULL
Sweden	NULL
)	NULL
.	NULL

Rapamycin	NULL
was	NULL
obtained	NULL
from	NULL
Biomol	NULL
(	NULL
Plymouth	NULL
Meeting	NULL
,	NULL
PA	NULL
)	NULL
.	NULL

PD	NULL
98059	NULL
,	NULL
KN-62	NULL
,	NULL
KN-93	NULL
,	NULL
Ly	NULL
294002	NULL
,	NULL
wortmannin	NULL
,	NULL
and	NULL
SB	NULL
203580	NULL
were	NULL
purchased	NULL
from	NULL
Calbiochem	NULL
(	NULL
La	NULL
Jolla	NULL
,	NULL
CA	NULL
)	NULL
.	NULL

Anti-CREB	NULL
Ab	NULL
recognizing	NULL
peptide	NULL
136-150	NULL
of	NULL
CREB	NULL
was	NULL
previously	NULL
described	NULL
(	NULL
48	NULL
)	NULL
.	NULL

Anti-phosphorylated	NULL
CREB	NULL
Ab	NULL
was	NULL
purchased	NULL
from	NULL
Upstate	NULL
Biotechnology	NULL
(	NULL
Lake	NULL
Placid	NULL
,	NULL
NY	NULL
)	NULL
.	NULL

Anti-CD28	NULL
Ab	NULL
37.51	NULL
,	NULL
generated	NULL
by	NULL
Dr.	NULL
James	NULL
Allison	NULL
(	NULL
University	NULL
of	NULL
California	NULL
,	NULL
Berkeley	NULL
,	NULL
CA	NULL
)	NULL
(	NULL
49	NULL
)	NULL
,	NULL
was	NULL
obtained	NULL
through	NULL
Dr.	NULL
Nan-Shih	NULL
Liao	NULL
(	NULL
Academia	NULL
Sinica	NULL
,	NULL
Taipei	NULL
,	NULL
Republic	NULL
of	NULL
China	NULL
)	NULL
.	NULL

Anti-phospho-Akt	NULL
(	NULL
Ser	NULL
``	NULL
)	NULL
Ab	NULL
was	NULL
purchased	NULL
from	NULL
New	NULL
England	NULL
Biolabs	NULL
(	NULL
Beverly	NULL
,	NULL
MA	NULL
)	NULL
.	NULL

T	NULL
cell	NULL
lines	NULL
and	NULL
cell	NULL
culture	NULL
ELA	NULL
T	NULL
lymphoma	NULL
cells	NULL
(	NULL
ATCC	NULL
TIB39	NULL
;	NULL
American	NULL
Type	NULL
Culture	NULL
Collection	NULL
,	NULL
Manassas	NULL
,	NULL
VA	NULL
)	NULL
were	NULL
a	NULL
gift	NULL
from	NULL
Dr.	NULL
Nan-Shih	NULL
Liao	NULL
.	NULL

Jurkat	NULL
cells	NULL
(	NULL
ATCC	NULL
TIB	NULL
152	NULL
)	NULL
were	NULL
obtained	NULL
from	NULL
Dr.	NULL
Chung-Yi	NULL
Wang	NULL
(	NULL
National	NULL
Yang-Ming	NULL
University	NULL
,	NULL
Taipei	NULL
,	NULL
Republic	NULL
of	NULL
China	NULL
)	NULL
.	NULL

All	NULL
cultures	NULL
were	NULL
performed	NULL
in	NULL
RPMI	NULL
with	NULL
10	NULL
%	NULL
FCS	NULL
(	NULL
both	NULL
from	NULL
Life	NULL
Technologies	NULL
,	NULL
Grand	NULL
Island	NULL
,	NULL
NY	NULL
)	NULL
,	NULL
10	NULL
mM	NULL
glutamine	NULL
,	NULL
100	NULL
U/ml	NULL
penicillin	NULL
,	NULL
100	NULL
U/ml	NULL
streptomycin	NULL
,	NULL
and	NULL
2	NULL
X	NULL
10~5	NULL
M	NULL
2-ME	NULL
.	NULL

Plasmids	NULL
CRE-chloramphenicol	NULL
acetyltransferase	NULL
(	NULL
CRE-CAT	NULL
)	NULL
was	NULL
previously	NULL
described	NULL
(	NULL
25	NULL
)	NULL
.	NULL

pVP16-CREB	NULL
and	NULL
pVP16-CREB	NULL
[	NULL
S133A	NULL
]	NULL
were	NULL
previously	NULL
described	NULL
(	NULL
50	NULL
)	NULL
.	NULL

pGAL-CREB-binding	NULL
domain	NULL
of	NULL
CBP	NULL
(	NULL
pGAL-CBD	NULL
)	NULL
encodes	NULL
fusion	NULL
protein	NULL
of	NULL
Gal	NULL
,	NULL
;	NULL
,	NULL
,	NULL
and	NULL
CBD	NULL
of	NULL
CBP	NULL
(	NULL
aa	NULL
461-682	NULL
)	NULL
.	NULL

RSV-CBP	NULL
was	NULL
a	NULL
gift	NULL
from	NULL
Dr.	NULL
Richard	NULL
H.	NULL
Goodman	NULL
(	NULL
Oregon	NULL
Health	NULL
Sciences	NULL
University	NULL
,	NULL
Portland	NULL
,	NULL
OR	NULL
)	NULL
.	NULL

pG	NULL
,	NULL
B-CAT	NULL
(	NULL
51	NULL
)	NULL
was	NULL
obtained	NULL
from	NULL
Dr.	NULL
Mark	NULL
Ptashne	NULL
(	NULL
Harvard	NULL
University	NULL
,	NULL
Boston	NULL
,	NULL
MA	NULL
)	NULL
.	NULL

PCNA-EH-CAT	NULL
(	NULL
abbreviated	NULL
as	NULL
PCNA-CAT	NULL
here	NULL
)	NULL
containing	NULL
a	NULL
213-bp	NULL
5	NULL
'	NULL
flanking	NULL
sequence	NULL
plus	NULL
intron	NULL
sequences	NULL
(	NULL
52	NULL
)	NULL
and	NULL
ZECRE-PCNA-EH-CAT	NULL
were	NULL
gifts	NULL
from	NULL
Dr.	NULL
Sun-Yu	NULL
Ng	NULL
(	NULL
Institute	NULL
of	NULL
Molecular	NULL
Medical	NULL
Sciences	NULL
,	NULL
Palo	NULL
Alto	NULL
,	NULL
CA	NULL
)	NULL
.	NULL

The	NULL
constitutively	NULL
active	NULL
form	NULL
of	NULL
MAPK	NULL
kinase	NULL
1	NULL
(	NULL
MKK1	NULL
)	NULL
,	NULL
pMCL-MKK1-N3/	NULL
S218E/8222D	NULL
(	NULL
53	NULL
)	NULL
,	NULL
was	NULL
a	NULL
gift	NULL
from	NULL
Dr.	NULL
Natalie	NULL
G.	NULL
Ahn	NULL
(	NULL
University	NULL
of	NULL
Colorado	NULL
,	NULL
Boulder	NULL
,	NULL
CO	NULL
)	NULL
.	NULL

The	NULL
active	NULL
mutant	NULL
of	NULL
MKK3b	NULL
(	NULL
MKK3b	NULL
(	NULL
Glu'*	NULL
>	NULL
,	NULL
Glu	NULL
'	NULL
``	NULL
``	NULL
)	NULL
(	NULL
54	NULL
)	NULL
and	NULL
MKK7	NULL
were	NULL
gifts	NULL
from	NULL
Dr.	NULL
Jiahuai	NULL
Han	NULL
(	NULL
Scripps	NULL
Research	NULL
285	NULL
Institute	NULL
,	NULL
La	NULL
Jolla	NULL
,	NULL
CA	NULL
)	NULL
.	NULL

Active	NULL
PI	NULL
3-kinase	NULL
p110*	NULL
(	NULL
55	NULL
)	NULL
was	NULL
a	NULL
gift	NULL
from	NULL
Dr.	NULL
Ruey-Hwa	NULL
Chen	NULL
(	NULL
National	NULL
Taiwan	NULL
University	NULL
,	NULL
Taipei	NULL
,	NULL
Republic	NULL
of	NULL
China	NULL
)	NULL
.	NULL

Nuclear	NULL
extract	NULL
and	NULL
total	NULL
cell	NULL
extract	NULL
T	NULL
cells	NULL
were	NULL
lysed	NULL
in	NULL
10	NULL
mM	NULL
Tris-HCI	NULL
(	NULL
pH	NULL
7.4	NULL
)	NULL
,	NULL
10	NULL
mM	NULL
NaCl	NULL
,	NULL
3	NULL
mM	NULL
MgCl	NULL
,	NULL
,	NULL
and	NULL
0.5	NULL
%	NULL
Nonidet	NULL
P-40	NULL
.	NULL

The	NULL
lysates	NULL
were	NULL
incubated	NULL
on	NULL
ice	NULL
for	NULL
5	NULL
min	NULL
and	NULL
centrifuged	NULL
at	NULL
1500	NULL
rpm	NULL
for	NULL
5	NULL
min	NULL
at	NULL
4°C	NULL
.	NULL

The	NULL
pellet	NULL
(	NULL
nuclei	NULL
)	NULL
was	NULL
suspended	NULL
in	NULL
hypertonic	NULL
buffer	NULL
containing	NULL
20	NULL
mM	NULL
HEPES	NULL
(	NULL
pH	NULL
7.9	NULL
)	NULL
,	NULL
1.5	NULL
mM	NULL
MgCl	NULL
,	NULL
,	NULL
0.3	NULL
M	NULL
KCI	NULL
,	NULL
0.5	NULL
mM	NULL
DTT	NULL
,	NULL
1	NULL
mM	NULL
PMSF	NULL
,	NULL
20	NULL
%	NULL
glycerol	NULL
,	NULL
and	NULL
0.4	NULL
mM	NULL
EDTA	NULL
and	NULL
were	NULL
rocked	NULL
at	NULL
4°C	NULL
for	NULL
>	NULL
30	NULL
min	NULL
.	NULL

The	NULL
mixture	NULL
was	NULL
centrifuged	NULL
at	NULL
13,000	NULL
rpm	NULL
for	NULL
10	NULL
min	NULL
.	NULL

The	NULL
supernatant	NULL
was	NULL
then	NULL
mixed	NULL
with	NULL
2	NULL
vol	NULL
of	NULL
the	NULL
above	NULL
buffer	NULL
(	NULL
without	NULL
KCI	NULL
)	NULL
and	NULL
immediately	NULL
frozen	NULL
.	NULL

Total	NULL
cell	NULL
extracts	NULL
were	NULL
prepared	NULL
by	NULL
resuspending	NULL
cells	NULL
in	NULL
hypotonic	NULL
buffer	NULL
containing	NULL
10	NULL
mM	NULL
HEPES	NULL
(	NULL
pH	NULL
7.9	NULL
)	NULL
,	NULL
1.5	NULL
mM	NULL
MgCl	NULL
,	NULL
,	NULL
10	NULL
mM	NULL
KCl	NULL
,	NULL
0.5	NULL
mM	NULL
DTT	NULL
,	NULL
0.5	NULL
mM	NULL
PMSF	NULL
,	NULL
100	NULL
g/m	NULL
!	NULL

aprotinin	NULL
,	NULL
and	NULL
1.25	NULL
pg/ml	NULL
leupeptin	NULL
and	NULL
were	NULL
lysed	NULL
by	NULL
three	NULL
cycles	NULL
of	NULL
freezing	NULL
and	NULL
thawing	NULL
.	NULL

One-tenth	NULL
volume	NULL
of	NULL
3	NULL
M	NULL
KCI	NULL
was	NULL
then	NULL
added	NULL
,	NULL
and	NULL
the	NULL
lysates	NULL
were	NULL
rocked	NULL
at	NULL
4°C	NULL
for	NULL
30	NULL
min	NULL
.	NULL

The	NULL
same	NULL
isolation	NULL
procedures	NULL
as	NULL
those	NULL
for	NULL
the	NULL
nuclear	NULL
extract	NULL
were	NULL
then	NULL
followed	NULL
.	NULL

Protein	NULL
concentration	NULL
was	NULL
determined	NULL
by	NULL
Bradford	NULL
assay	NULL
(	NULL
Bio-Rad	NULL
,	NULL
Richmond	NULL
,	NULL
CA	NULL
)	NULL
.	NULL

Immunoblots	NULL
Cell	NULL
extracts	NULL
(	NULL
10-30	NULL
pg	NULL
)	NULL
were	NULL
resolved	NULL
by	NULL
10	NULL
%	NULL
SDS-PAGE	NULL
and	NULL
transferred	NULL
to	NULL
polyvinylidene	NULL
difluoride	NULL
membrane	NULL
(	NULL
Millipore	NULL
,	NULL
Bedford	NULL
,	NULL
MA	NULL
)	NULL
for	NULL
4	NULL
h	NULL
at	NULL
20	NULL
V.	NULL
Membranes	NULL
were	NULL
washed	NULL
in	NULL
rinse	NULL
buffer	NULL
(	NULL
PBS	NULL
with	NULL
2	NULL
%	NULL
Tween	NULL
20	NULL
)	NULL
at	NULL
room	NULL
temperature	NULL
for	NULL
15	NULL
min	NULL
and	NULL
incubated	NULL
in	NULL
blocking	NULL
buffer	NULL
(	NULL
5	NULL
%	NULL
nonfat	NULL
milk	NULL
in	NULL
rinse	NULL
buffer	NULL
)	NULL
for	NULL
1.5	NULL
h.	NULL
The	NULL
membrane	NULL
was	NULL
then	NULL
incubated	NULL
with	NULL
0.1	NULL
ug/ml	NULL
anti-phosphorylated	NULL
CREB	NULL
or	NULL
2	NULL
ug/ml	NULL
anti-CREB	NULL
.	NULL

After	NULL
washing	NULL
,	NULL
the	NULL
membrane	NULL
was	NULL
incubated	NULL
with	NULL
HRP-conjugated	NULL
anti-rabbit	NULL
Ig	NULL
Ab	NULL
(	NULL
Santa	NULL
Cruz	NULL
Biotechnology	NULL
,	NULL
Santa	NULL
Cruz	NULL
,	NULL
CA	NULL
)	NULL
in	NULL
blocking	NULL
buffer	NULL
for	NULL
1.5	NULL
h.	NULL
After	NULL
washing	NULL
three	NULL
times	NULL
,	NULL
membranes	NULL
were	NULL
developed	NULL
by	NULL
ECL	NULL
Western	NULL
blot	NULL
detection	NULL
reagents	NULL
(	NULL
Amersham	NULL
,	NULL
Aylesbury	NULL
,	NULL
U.K.	NULL
)	NULL
.	NULL

The	NULL
developed	NULL
membrane	NULL
was	NULL
detected	NULL
using	NULL
x-ray	NULL
film	NULL
and	NULL
was	NULL
quantitated	NULL
using	NULL
a	NULL
densitometer	NULL
(	NULL
Molecular	NULL
Dynamics	NULL
,	NULL
Sunnyvale	NULL
,	NULL
CA	NULL
)	NULL
.	NULL

Transfection	NULL
ELA	NULL
cells	NULL
(	NULL
1.6	NULL
X	NULL
10	NULL
``	NULL
)	NULL
were	NULL
washed	NULL
once	NULL
with	NULL
STBS	NULL
(	NULL
25	NULL
mM	NULL
Tris-HCl	NULL
,	NULL
pH	NULL
7.4	NULL
,	NULL
137	NULL
mM	NULL
NaCl	NULL
,	NULL
5	NULL
mM	NULL
KCl	NULL
,	NULL
0.6	NULL
mM	NULL
Na	NULL
,	NULL
HPO	NULL
,	NULL
,	NULL
0.7	NULL
mM	NULL
CaCl	NULL
,	NULL
,	NULL
and	NULL
0.5	NULL
mM	NULL
and	NULL
incubated	NULL
with	NULL
a	NULL
total	NULL
of	NULL
10	NULL
pg	NULL
of	NULL
DNA	NULL
in	NULL
1.2	NULL
ml	NULL
of	NULL
STBS	NULL
containing	NULL
0.5	NULL
mg/ml	NULL
DEAE-dextran	NULL
for	NULL
20	NULL
min	NULL
at	NULL
room	NULL
temperature	NULL
.	NULL

One	NULL
microgram	NULL
of	NULL
pGreen	NULL
Lantern-1	NULL
(	NULL
Life	NULL
Technologies	NULL
)	NULL
was	NULL
included	NULL
in	NULL
all	NULL
transfections	NULL
.	NULL

EL4	NULL
cells	NULL
were	NULL
then	NULL
treated	NULL
with	NULL
15	NULL
%	NULL
DMSO	NULL
for	NULL
3	NULL
min	NULL
and	NULL
washed	NULL
once	NULL
with	NULL
STBS	NULL
.	NULL

The	NULL
transfection	NULL
efficiency	NULL
was	NULL
determined	NULL
24	NULL
h	NULL
after	NULL
transfection	NULL
by	NULL
counting	NULL
the	NULL
fraction	NULL
of	NULL
green	NULL
fluorescence	NULL
cells	NULL
.	NULL

The	NULL
cells	NULL
were	NULL
activated	NULL
and	NULL
harvested	NULL
6-24	NULL
h	NULL
after	NULL
activation	NULL
.	NULL

The	NULL
CAT	NULL
activities	NULL
were	NULL
measured	NULL
as	NULL
previously	NULL
described	NULL
(	NULL
56	NULL
)	NULL
and	NULL
were	NULL
normalized	NULL
by	NULL
the	NULL
transfection	NULL
efficiency	NULL
.	NULL

Protein	NULL
kinase	NULL
assays	NULL
T	NULL
cells	NULL
were	NULL
treated	NULL
with	NULL
immobilized	NULL
anti-CD3	NULL
and	NULL
anti-CD28	NULL
Ab	NULL
,	NULL
and	NULL
cell	NULL
lysates	NULL
were	NULL
prepared	NULL
20	NULL
min	NULL
after	NULL
activation	NULL
.	NULL

One	NULL
hundred	NULL
to	NULL
200	NULL
ug	NULL
of	NULL
lysate	NULL
was	NULL
precipitated	NULL
with	NULL
1	NULL
pug	NULL
of	NULL
anti-ERK2	NULL
Ab	NULL
(	NULL
Santa	NULL
Cruz	NULL
Biotechnology	NULL
;	NULL
C-14	NULL
)	NULL
for	NULL
ERK	NULL
assay	NULL
(	NULL
57	NULL
)	NULL
,	NULL
1	NULL
ul	NULL
of	NULL
anti-JNK1	NULL
Ab1O1	NULL
(	NULL
58	NULL
)	NULL
for	NULL
JNK	NULL
assay	NULL
,	NULL
1	NULL
ug	NULL
of	NULL
anti-p38	NULL
@	NULL
polyclonal	NULL
Ab	NULL
(	NULL
59	NULL
)	NULL
for	NULL
p38	NULL
MAPK	NULL
assay	NULL
,	NULL
or	NULL
1	NULL
ug	NULL
of	NULL
anti-CaMKIV	NULL
Ab	NULL
(	NULL
Santa	NULL
Cruz	NULL
Biotechnology	NULL
;	NULL
C-20	NULL
)	NULL
for	NULL
CaMKIV	NULL
assay	NULL
followed	NULL
by	NULL
20	NULL
pl	NULL
of	NULL
protein	NULL
A-Sepharose	NULL
.	NULL

The	NULL
kinase	NULL
activity	NULL
of	NULL
the	NULL
immune	NULL
complexes	NULL
was	NULL
determined	NULL
using	NULL
myelin	NULL
basic	NULL
protein	NULL
as	NULL
substrate	NULL
for	NULL
the	NULL
ERK	NULL
assay	NULL
,	NULL
GST-c-Jun	NULL
,	NULL
_	NULL
;	NULL
,	NULL
for	NULL
the	NULL
JNK	NULL
assay	NULL
,	NULL
GST-ATFE-2	NULL
,	NULL
_199	NULL
for	NULL
the	NULL
p38	NULL
MAPK	NULL
assay	NULL
,	NULL
and	NULL
GST-CREB	NULL
for	NULL
the	NULL
CaMKIV	NULL
assay	NULL
.	NULL

The	NULL
reaction	NULL
mixtures	NULL
were	NULL
resolved	NULL
on	NULL
SDS-PAGE	NULL
followed	NULL
by	NULL
autoradiography	NULL
and	NULL
were	NULL
quantitated	NULL
by	NULL
PhosphorImager	NULL
(	NULL
Molecular	NULL
Dynamics	NULL
)	NULL
.	NULL

Results	NULL
Requirement	NULL
of	NULL
CD3/CD28	NULL
costimulation	NULL
for	NULL
CREB-CBP	NULL
interaction	NULL
We	NULL
used	NULL
reporters	NULL
pGAL-CBD	NULL
and	NULL
pVP16-CREB	NULL
(	NULL
50	NULL
)	NULL
to	NULL
measure	NULL
the	NULL
interaction	NULL
of	NULL
CREB	NULL
and	NULL
CBP	NULL
(	NULL
Fig	NULL
.	NULL

14	NULL
)	NULL
.	NULL

pGAL-CBD	NULL
encodes	NULL
the	NULL
fusion	NULL
protein	NULL
of	NULL
Gal	NULL
,	NULL
;	NULL
,	NULL
,	NULL
and	NULL
the	NULL
CBD	NULL
of	NULL
CBP	NULL
(	NULL
aa	NULL
461-682	NULL
)	NULL
.	NULL

The	NULL
activation	NULL
of	NULL
pG	NULL
,	NULL
B-CAT	NULL
upon	NULL
binding	NULL
of	NULL
CBP	NULL
to	NULL
CREB	NULL
was	NULL
used	NULL
as	NULL
a	NULL
readout	NULL
for	NULL
the	NULL
assay	NULL
.	NULL

Stimulation	NULL
through	NULL
CD3	NULL
alone	NULL
or	NULL
CD28	NULL
alone	NULL
failed	NULL
to	NULL
promote	NULL
the	NULL
binding	NULL
of	NULL
CREB	NULL
to	NULL
CBP	NULL
(	NULL
Fig	NULL
.	NULL

1B	NULL
)	NULL
.	NULL

CREB-CBP	NULL
interaction	NULL
was	NULL
detectable	NULL
only	NULL
upon	NULL
costimulation	NULL
of	NULL
CD3	NULL
and	NULL
CD28	NULL
.	NULL

The	NULL
interaction	NULL
was	NULL
dependent	NULL
on	NULL
the	NULL
6107	NULL
'0t	NULL
4epy	NULL
uo	NULL
1san8	NULL
4q	NULL
[	NULL
810	NULL
fountwrut	NULL
[	NULL
'mmmy	NULL
;	NULL
/	NULL
:	NULL
dyy	NULL
wor	NULL
286	NULL
A.	NULL
CBP	NULL
\	NULL
GAL4	NULL
GSB	NULL
B	NULL
1	NULL
-	NULL
+pVP16-CREB	NULL
E	NULL
e	NULL
s	NULL
10	NULL
<	NULL
6	NULL
<	NULL
ro	NULL
C	NULL
-	NULL
5	NULL
Em	NULL
0	NULL
@	NULL
]	NULL
(	NULL
@	NULL
]	NULL
a	NULL
a	NULL
o	NULL
lel	NULL
g	NULL
ht	NULL
&	NULL
e	NULL
bo	NULL
&	NULL
e	NULL
co	NULL
fy	NULL
]	NULL
Co	NULL
c.	NULL
10	NULL
+pVP16-CREB	NULL
[	NULL
S	NULL
$	NULL
133A	NULL
]	NULL
&	NULL
-	NULL
<	NULL
s	NULL
Rs	NULL
bst	NULL
<	NULL
4	NULL
©	NULL
E	NULL
s	NULL
0g	NULL
A	NULL
&	NULL
&	NULL
O	NULL
ta	NULL
co	NULL
FIGURE	NULL
1	NULL
.	NULL

Costimulation	NULL
of	NULL
CD3	NULL
and	NULL
CD28	NULL
is	NULL
required	NULL
for	NULL
binding	NULL
of	NULL
CREB	NULL
to	NULL
CBP	NULL
.	NULL

A	NULL
,	NULL
Interaction	NULL
of	NULL
CBP	NULL
and	NULL
CREB	NULL
as	NULL
determined	NULL
by	NULL
pGAL-CBD	NULL
,	NULL
pVP16-CREB	NULL
,	NULL
and	NULL
pG	NULL
,	NULL
B-CAT	NULL
.	NULL

B	NULL
,	NULL
ELA	NULL
T	NULL
cells	NULL
were	NULL
transfected	NULL
with	NULL
pGAL-CBD	NULL
,	NULL
pVP16-CREB	NULL
,	NULL
pG	NULL
,	NULL
B-CAT	NULL
,	NULL
and	NULL
1	NULL
pug	NULL
of	NULL
pGreen	NULL
Lantern-1	NULL
by	NULL
DEAE-dextran	NULL
methods	NULL
.	NULL

Twenty-four	NULL
hours	NULL
later	NULL
T	NULL
cells	NULL
were	NULL
stimulated	NULL
with	NULL
immobilized	NULL
anti-CD3	NULL
(	NULL
2C11	NULL
;	NULL
5	NULL
ug/ml	NULL
!	NULL
)	NULL

and/or	NULL
anti-CD28	NULL
(	NULL
38.51	NULL
;	NULL
2.5	NULL
pg/tal	NULL
)	NULL
.	NULL

T	NULL
cells	NULL
extract	NULL
were	NULL
prepared	NULL
after	NULL
another	NULL
24	NULL
h.	NULL
CAT	NULL
activities	NULL
were	NULL
determined	NULL
and	NULL
normalized	NULL
by	NULL
the	NULL
transfection	NULL
efficiency	NULL
assessed	NULL
through	NULL
green	NULL
fluorescence	NULL
protein	NULL
expression	NULL
.	NULL

C	NULL
,	NULL
ELA	NULL
cells	NULL
were	NULL
treated	NULL
as	NULL
described	NULL
in	NULL
B	NULL
,	NULL
except	NULL
that	NULL
pVP16-CREB	NULL
was	NULL
replaced	NULL
with	NULL
pVP16-CREB	NULL
[	NULL
S133A	NULL
]	NULL
.	NULL

The	NULL
value	NULL
is	NULL
the	NULL
mean	NULL
of	NULL
three	NULL
measurements	NULL
.	NULL

SD	NULL
is	NULL
expressed	NULL
as	NULL
an	NULL
error	NULL
bar	NULL
.	NULL

phosphorylation	NULL
of	NULL
CREB	NULL
Ser'*	NULL
>	NULL
.	NULL

Substitution	NULL
of	NULL
pVP16-CREB	NULL
with	NULL
pVP16-CREB	NULL
[	NULL
S133A	NULL
]	NULL
abrogated	NULL
the	NULL
CREB-CBP	NULL
binding	NULL
induced	NULL
by	NULL
CD3/CD28	NULL
(	NULL
Fig	NULL
.	NULL

1C	NULL
)	NULL
.	NULL

CD3/CD28	NULL
costimulation-promoted	NULL
CREB-CBP	NULL
interaction	NULL
involves	NULL
ERK	NULL
,	NULL
p38	NULL
MAPK	NULL
,	NULL
and	NULL
CaMKIV	NULL
pathways	NULL
Inhibitors	NULL
for	NULL
different	NULL
kinases	NULL
were	NULL
used	NULL
to	NULL
assess	NULL
the	NULL
contribution	NULL
of	NULL
each	NULL
kinase	NULL
to	NULL
CREB-CBP	NULL
interaction	NULL
.	NULL

As	NULL
illustrated	NULL
in	NULL
Fig	NULL
.	NULL

24	NULL
,	NULL
PD	NULL
98059	NULL
(	NULL
10	NULL
uM	NULL
)	NULL
reduced	NULL
the	NULL
activation	NULL
of	NULL
pGAL-CBD	NULL
by	NULL
50	NULL
%	NULL
,	NULL
supporting	NULL
the	NULL
previous	NULL
note	NULL
that	NULL
the	NULL
ERK	NULL
cascade	NULL
is	NULL
an	NULL
essential	NULL
pathway	NULL
for	NULL
CREB	NULL
frans-activation	NULL
(	NULL
25	NULL
)	NULL
.	NULL

KN-62	NULL
(	NULL
10	NULL
M	NULL
)	NULL
,	NULL
the	NULL
antagonist	NULL
of	NULL
both	NULL
CaMKII	NULL
and	NULL
CaMKIV	NULL
,	NULL
was	NULL
as	NULL
potent	NULL
as	NULL
PD	NULL
98059	NULL
CD3/CD28-INDUCED	NULL
CREB-CBP	NULL
INTERACTION	NULL
10	NULL
Fold	NULL
Activation	NULL
(	NULL
CAT	NULL
)	NULL
L9	NULL
;	NULL
8T/EC	NULL
TONM+8T/EC	NULL
€6NM+8T/ECL	NULL
US+ZINM+CII+8ZT/ECL	NULL
10	NULL
Fold	NULL
Activation	NULL
(	NULL
CAT	NULL
)	NULL
tn	NULL
AT+8T/E0O	NULL
DD+8T/E0O	NULL
U+8T/ECO	NULL
68H+8T/E0LD	NULL
CDMS	NULL
-	NULL
j	NULL
+	NULL
+	NULL
+	NULL
PD	NULL
-o	NULL
~=	NULL
#	NULL
€	NULL
.	NULL

(	NULL
&	NULL
)	NULL
.	NULL

%	NULL
KN62	NULL
-	NULL
-	NULL
-	NULL
+	NULL
SB	NULL
~	NULL
~	NULL
.	NULL

ERK	NULL
.~	NULL
»	NULL
am	NULL
as	NULL
-o	NULL
+	NULL
-	NULL
<	NULL
-	NULL
MBP	NULL
p38	NULL
MAPK	NULL
<	NULL
-	NULL
GST-ATF2	NULL
CaM	NULL
Kinase	NULL
IV	NULL
«	NULL
lite	NULL
-A-	NULL
GST-CREB	NULL
FIGURE	NULL
2	NULL
.	NULL

-	NULL
Involvement	NULL
of	NULL
ERK	NULL
,	NULL
p38	NULL
MAPK	NULL
,	NULL
and	NULL
CaMKIV	NULL
in	NULL
CREB-CBP	NULL
interaction	NULL
induced	NULL
by	NULL
CD3/CD28	NULL
.	NULL

A	NULL
,	NULL
EL4	NULL
T	NULL
cells	NULL
were	NULL
transfected	NULL
with	NULL
pGAL-CBD	NULL
,	NULL
CREB-VP16	NULL
,	NULL
pG	NULL
,	NULL
B-CAT	NULL
,	NULL
and	NULL
1	NULL
pug	NULL
of	NULL
pGreen	NULL
Lantern-1	NULL
by	NULL
DEAE-dextran	NULL
method	NULL
and	NULL
then	NULL
activated	NULL
with	NULL
anti-CD3	NULL
plus	NULL
anti-CD28	NULL
after	NULL
24	NULL
h.	NULL
Kinase	NULL
inhibitors	NULL
were	NULL
added	NULL
immediately	NULL
after	NULL
T	NULL
cell	NULL
activation	NULL
.	NULL

CAT	NULL
activities	NULL
were	NULL
determined	NULL
24	NULL
h	NULL
after	NULL
T	NULL
cell	NULL
activation	NULL
.	NULL

The	NULL
inhibitors	NULL
used	NULL
were	NULL
PD	NULL
098059	NULL
(	NULL
PD	NULL
;	NULL
10	NULL
uM	NULL
)	NULL
,	NULL
KN-62	NULL
(	NULL
10	NULL
uM	NULL
)	NULL
,	NULL
KN-93	NULL
(	NULL
10	NULL
uM	NULL
)	NULL
,	NULL
and	NULL
SB	NULL
203580	NULL
(	NULL
10	NULL
uM	NULL
)	NULL
.	NULL

B	NULL
,	NULL
CREB-CBP	NULL
interaction	NULL
was	NULL
not	NULL
mediated	NULL
by	NULL
PKA	NULL
,	NULL
p70	NULL
S6	NULL
kinase	NULL
,	NULL
or	NULL
PI	NULL
3-kinase	NULL
.	NULL

EL4	NULL
T	NULL
cells	NULL
were	NULL
treated	NULL
as	NULL
described	NULL
in	NULL
A	NULL
with	NULL
the	NULL
following	NULL
inhibitors	NULL
:	NULL
LY	NULL
294002	NULL
(	NULL
LY	NULL
;	NULL
10	NULL
M	NULL
)	NULL
,	NULL
H89	NULL
(	NULL
1	NULL
pM	NULL
)	NULL
,	NULL
calphostin	NULL
C	NULL
(	NULL
CC	NULL
;	NULL
2	NULL
M	NULL
)	NULL
,	NULL
or	NULL
rapamycin	NULL
(	NULL
R	NULL
;	NULL
50	NULL
ng/ml	NULL
)	NULL
.	NULL

C	NULL
,	NULL
ELA	NULL
T	NULL
cells	NULL
were	NULL
pretreated	NULL
with	NULL
PD	NULL
098059	NULL
,	NULL
KN-62	NULL
,	NULL
SB	NULL
203580	NULL
,	NULL
or	NULL
0.1	NULL
%	NULL
DMSO	NULL
(	NULL
control	NULL
)	NULL
for	NULL
20	NULL
min	NULL
.	NULL

T	NULL
cells	NULL
were	NULL
then	NULL
stimulated	NULL
with	NULL
anti-CD3	NULL
plus	NULL
anti-CD28	NULL
,	NULL
and	NULL
the	NULL
cell	NULL
extracts	NULL
were	NULL
prepared	NULL
20	NULL
min	NULL
after	NULL
activation	NULL
.	NULL

ERK	NULL
,	NULL
p38	NULL
MAPK	NULL
,	NULL
and	NULL
CaMKIV	NULL
activities	NULL
were	NULL
determined	NULL
by	NULL
immunoprecipitation	NULL
of	NULL
the	NULL
cell	NULL
lysates	NULL
with	NULL
specific	NULL
Abs	NULL
.	NULL

One	NULL
hundred	NULL
to	NULL
200	NULL
ug	NULL
of	NULL
lysate	NULL
was	NULL
precipitated	NULL
with	NULL
1	NULL
ug	NULL
of	NULL
anti-ERK2	NULL
C-14	NULL
Ab	NULL
(	NULL
Santa	NULL
Cruz	NULL
Biotechnology	NULL
)	NULL
,	NULL
anti-p38	NULL
«	NULL
Ab	NULL
(	NULL
59	NULL
)	NULL
,	NULL
or	NULL
anti-CaMKIV	NULL
C-20	NULL
Ab	NULL
(	NULL
Santa	NULL
Cruz	NULL
Biotechnology	NULL
)	NULL
followed	NULL
by	NULL
protein	NULL
A-Sepharose	NULL
.	NULL

The	NULL
kinase	NULL
activity	NULL
of	NULL
the	NULL
immune	NULL
complexes	NULL
was	NULL
determined	NULL
by	NULL
the	NULL
phosphorylation	NULL
of	NULL
myelin	NULL
basic	NULL
protein	NULL
(	NULL
MBP	NULL
)	NULL
for	NULL
ERK	NULL
,	NULL
GST-ATF-2	NULL
;	NULL
,	NULL
;	NULL
,	NULL
,	NULL
for	NULL
p38	NULL
MAPK	NULL
,	NULL
and	NULL
GST-CREB	NULL
for	NULL
CaMKIV	NULL
,	NULL
as	NULL
resolved	NULL
on	NULL
SDS-PAGE	NULL
.	NULL

in	NULL
reducing	NULL
CREB-CBP	NULL
interaction	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
CaMKII-specific	NULL
inhibitor	NULL
KN-93	NULL
did	NULL
not	NULL
interfere	NULL
with	NULL
the	NULL
binding	NULL
of	NULL
CREB	NULL
to	NULL
CBP	NULL
(	NULL
Fig	NULL
.	NULL

24	NULL
)	NULL
.	NULL

The	NULL
inhibition	NULL
by	NULL
KN-62	NULL
,	NULL
but	NULL
not	NULL
KN-93	NULL
,	NULL
thus	NULL
suggests	NULL
the	NULL
involvement	NULL
of	NULL
CaMKIV	NULL
in	NULL
CREB	NULL
frans-activation	NULL
.	NULL

6107	NULL
'0t	NULL
4epy	NULL
uo	NULL
1san8	NULL
4q	NULL
[	NULL
810	NULL
fountwrut	NULL
[	NULL
'mmmy	NULL
;	NULL
/	NULL
:	NULL
dyy	NULL
wor	NULL
The	NULL
Journal	NULL
of	NULL
Immunology	NULL
The	NULL
inhibitor	NULL
SB	NULL
203590	NULL
(	NULL
10	NULL
uM	NULL
)	NULL
was	NULL
found	NULL
to	NULL
suppress	NULL
>	NULL
60	NULL
%	NULL
of	NULL
the	NULL
CREB-CBP	NULL
interaction	NULL
.	NULL

A	NULL
combination	NULL
of	NULL
PD	NULL
98059	NULL
,	NULL
KN	NULL
62	NULL
,	NULL
and	NULL
SB	NULL
203580	NULL
completely	NULL
blocked	NULL
CD3/CD28-promoted	NULL
CREB-CBP	NULL
binding	NULL
(	NULL
Fig	NULL
.	NULL

24	NULL
)	NULL
.	NULL

The	NULL
specificity	NULL
of	NULL
PD	NULL
98059	NULL
,	NULL
SB	NULL
203590	NULL
,	NULL
and	NULL
KN-62	NULL
was	NULL
confirmed	NULL
using	NULL
kinase	NULL
assays	NULL
(	NULL
Fig	NULL
.	NULL

2C	NULL
)	NULL
.	NULL

PD	NULL
98059	NULL
selectively	NULL
inhibited	NULL
the	NULL
activation	NULL
ERK	NULL
,	NULL
but	NULL
not	NULL
p38	NULL
MAPK	NULL
and	NULL
CaMKIV	NULL
,	NULL
induced	NULL
by	NULL
CD3/CD28	NULL
.	NULL

Similarly	NULL
,	NULL
SB	NULL
203580	NULL
antagonized	NULL
only	NULL
38	NULL
MAPK	NULL
and	NULL
KN-62	NULL
specifically	NULL
suppressed	NULL
CaMKIV	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
inhibition	NULL
of	NULL
PI	NULL
3-kinase	NULL
,	NULL
protein	NULL
kinase	NULL
A	NULL
,	NULL
protein	NULL
kinase	NULL
C	NULL
,	NULL
and	NULL
p70	NULL
S6	NULL
kinase	NULL
only	NULL
weakly	NULL
interfered	NULL
with	NULL
CREB-CBP	NULL
interaction	NULL
(	NULL
Fig	NULL
.	NULL

2B	NULL
)	NULL
.	NULL

Because	NULL
PI	NULL
3-kinase	NULL
is	NULL
known	NULL
to	NULL
be	NULL
activated	NULL
by	NULL
CD28	NULL
(	NULL
35-37	NULL
)	NULL
,	NULL
and	NULL
PI	NULL
3-kinase	NULL
activation	NULL
promotes	NULL
CREB	NULL
phosphorylation	NULL
(	NULL
21	NULL
)	NULL
,	NULL
we	NULL
also	NULL
examined	NULL
binding	NULL
with	NULL
another	NULL
PI	NULL
3-kinase	NULL
inhibitor	NULL
,	NULL
wortmannin	NULL
,	NULL
and	NULL
did	NULL
not	NULL
detect	NULL
any	NULL
inhibitory	NULL
effect	NULL
on	NULL
CREB-CBP	NULL
binding	NULL
(	NULL
Not	NULL
shown	NULL
)	NULL
.	NULL

Therefore	NULL
,	NULL
CD28	NULL
costimulation-induced	NULL
CREB-CBP	NULL
binding	NULL
is	NULL
mainly	NULL
dependent	NULL
on	NULL
the	NULL
ERK	NULL
,	NULL
CaMKIV	NULL
,	NULL
and	NULL
p38	NULL
MAPK	NULL
pathways	NULL
.	NULL

CD3/CD28-costimulated	NULL
CREB	NULL
trans-activation	NULL
requires	NULL
ERK	NULL
,	NULL
p38	NULL
MAPK	NULL
,	NULL
and	NULL
CaMKIV	NULL
pathways	NULL
Because	NULL
CREB-CBP	NULL
binding	NULL
may	NULL
not	NULL
necessarily	NULL
represent	NULL
the	NULL
activation	NULL
of	NULL
CREB	NULL
(	NULL
24	NULL
,	NULL
60	NULL
,	NULL
61	NULL
)	NULL
,	NULL
we	NULL
further	NULL
used	NULL
CRE-CAT	NULL
to	NULL
assess	NULL
the	NULL
transcription	NULL
activity	NULL
of	NULL
CREB	NULL
(	NULL
Fig	NULL
.	NULL

3	NULL
)	NULL
.	NULL

We	NULL
previously	NULL
illustrated	NULL
that	NULL
CRE-CAT	NULL
is	NULL
activated	NULL
by	NULL
CD3	NULL
plus	NULL
CD28	NULL
,	NULL
but	NULL
not	NULL
by	NULL
CD3	NULL
or	NULL
CD28	NULL
alone	NULL
(	NULL
25	NULL
)	NULL
.	NULL

The	NULL
signaling	NULL
requirement	NULL
of	NULL
the	NULL
CD3/CD28	NULL
costimulation-induced	NULL
CRE-CAT	NULL
expression	NULL
was	NULL
similarly	NULL
determined	NULL
.	NULL

The	NULL
presence	NULL
of	NULL
PD	NULL
98059	NULL
or	NULL
KN-62	NULL
reduced	NULL
the	NULL
activation	NULL
of	NULL
CRE-CAT	NULL
by	NULL
35	NULL
%	NULL
,	NULL
while	NULL
SB	NULL
203580	NULL
suppressed	NULL
>	NULL
45	NULL
%	NULL
of	NULL
CRE-CAT	NULL
expression	NULL
.	NULL

The	NULL
combination	NULL
of	NULL
PD	NULL
98059	NULL
,	NULL
KN-62	NULL
,	NULL
and	NULL
SB	NULL
203580	NULL
abrogated	NULL
the	NULL
activation	NULL
of	NULL
CRE-CAT	NULL
stimulated	NULL
by	NULL
CD3/CD28	NULL
(	NULL
Fig	NULL
.	NULL

3	NULL
)	NULL
.	NULL

ERK	NULL
,	NULL
p38	NULL
MAPK	NULL
,	NULL
and	NULL
CaMKIV	NULL
were	NULL
similarly	NULL
involved	NULL
in	NULL
the	NULL
trans-activation	NULL
of	NULL
CREB	NULL
induced	NULL
by	NULL
CD3/CD28	NULL
.	NULL

CRE-CAT	NULL
Fold	NULL
Activation	NULL
|=	NULL
9	NULL
&	NULL
a	NULL
8STKCD	NULL
Ud+87T/£	NULL
(	NULL
D	NULL
TINM+8TIEUD	NULL
as+0d+IINM+8T/E0	NULL
,	NULL
)	NULL
FIGURE	NULL
3	NULL
.	NULL

-	NULL
Involvement	NULL
of	NULL
ERK	NULL
,	NULL
p38	NULL
MAPK	NULL
,	NULL
and	NULL
CaMKIV	NULL
in	NULL
CREB	NULL
trans-activation	NULL
.	NULL

ELA	NULL
T	NULL
cells	NULL
were	NULL
transfected	NULL
with	NULL
CRE-CAT	NULL
and	NULL
pGreen	NULL
Lantern-1	NULL
,	NULL
and	NULL
then	NULL
activated	NULL
with	NULL
CD3/CD28	NULL
24	NULL
h	NULL
later	NULL
.	NULL

Different	NULL
inhibitors	NULL
were	NULL
added	NULL
immediately	NULL
after	NULL
T	NULL
cell	NULL
activation	NULL
.	NULL

CAT	NULL
activity	NULL
was	NULL
determined	NULL
after	NULL
another	NULL
24	NULL
h.	NULL
287	NULL
p38	NULL
MAPK	NULL
and	NULL
CaMKIV	NULL
are	NULL
activated	NULL
by	NULL
CD3	NULL
or	NULL
CD28	NULL
alone	NULL
and	NULL
are	NULL
further	NULL
stimulated	NULL
by	NULL
CD3/CD28	NULL
costimulation	NULL
We	NULL
next	NULL
determined	NULL
the	NULL
activation	NULL
of	NULL
MAPKK	NULL
,	NULL
p38	NULL
MAPK	NULL
,	NULL
and	NULL
CaMKIV	NULL
when	NULL
T	NULL
cells	NULL
were	NULL
stimulated	NULL
by	NULL
CD3	NULL
,	NULL
CD28	NULL
,	NULL
or	NULL
both	NULL
(	NULL
Fig	NULL
.	NULL

4	NULL
)	NULL
.	NULL

ERK	NULL
is	NULL
activated	NULL
by	NULL
CD3	NULL
and	NULL
is	NULL
not	NULL
affected	NULL
by	NULL
CD28	NULL
costimulation	NULL
(	NULL
41	NULL
)	NULL
.	NULL

Fig	NULL
.	NULL

44	NULL
confirms	NULL
that	NULL
CD28	NULL
engagement	NULL
did	NULL
not	NULL
stimulate	NULL
ERK	NULL
.	NULL

ERK	NULL
activation	NULL
was	NULL
identical	NULL
when	NULL
T	NULL
cells	NULL
were	NULL
stimulated	NULL
by	NULL
CD3	NULL
or	NULL
by	NULL
CD3/CD28	NULL
(	NULL
Fig	NULL
.	NULL

4B	NULL
)	NULL
.	NULL

We	NULL
and	NULL
others	NULL
have	NULL
shown	NULL
that	NULL
p38	NULL
MAPK	NULL
activity	NULL
is	NULL
stimulated	NULL
by	NULL
CD3	NULL
and	NULL
is	NULL
further	NULL
enhanced	NULL
by	NULL
CD3/CD28	NULL
costimulation	NULL
(	NULL
43	NULL
,	NULL
44	NULL
)	NULL
.	NULL

Here	NULL
we	NULL
observed	NULL
that	NULL
p38	NULL
MAPK	NULL
was	NULL
also	NULL
activated	NULL
by	NULL
CD28	NULL
alone	NULL
(	NULL
Fig	NULL
.	NULL

4A	NULL
)	NULL
.	NULL

CD28-stimulated	NULL
p38	NULL
activation	NULL
was	NULL
slightly	NULL
lower	NULL
than	NULL
that	NULL
stimulated	NULL
by	NULL
CD3	NULL
(	NULL
Fig	NULL
.	NULL

4B	NULL
)	NULL
.	NULL

Both	NULL
CD3	NULL
and	NULL
CD28	NULL
ligation	NULL
alone	NULL
led	NULL
to	NULL
activation	NULL
of	NULL
CaMKIV	NULL
to	NULL
a	NULL
similar	NULL
extent	NULL
.	NULL

CaMKIV	NULL
activation	NULL
was	NULL
further	NULL
augmented	NULL
by	NULL
CD3/CD28	NULL
costimulation	NULL
(	NULL
Fig	NULL
.	NULL

4	NULL
)	NULL
.	NULL

Of	NULL
the	NULL
three	NULL
kinases	NULL
required	NULL
for	NULL
CREB-CBP	NULL
binding	NULL
,	NULL
p38	NULL
MAPK	NULL
and	NULL
CaMKIV	NULL
were	NULL
activated	NULL
by	NULL
both	NULL
CD3	NULL
and	NULL
CD28	NULL
alone	NULL
.	NULL

A	NULL
CD3	NULL
0	NULL
-o	NULL
+	NULL
-	NULL
O+	NULL
CD8	NULL
00	NULL
~	NULL
op	NULL
+	NULL
UW	NULL
ERK	NULL
'	NULL
p38	NULL
MAPK	NULL
wa	NULL
aan	NULL
#	NULL
B	NULL
--	NULL
CST-ATF2	NULL
CaM	NULL
Kinase	NULL
IV	NULL
«	NULL
ae	NULL
ame	NULL
--	NULL
-	NULL
GST-CREB	NULL
a	NULL
807	NULL
e	NULL
e	NULL
ERK	NULL
c	NULL
6	NULL
T	NULL
E	NULL
607	NULL
&	NULL
&	NULL
40	NULL
{	NULL
8	NULL
<	NULL
a	NULL
201	NULL
w	NULL
a	NULL
£	NULL
.	NULL

,	NULL
x	NULL
z-	NULL
q	NULL
ao	NULL
o	NULL
5	NULL
E	NULL
§	NULL
§	NULL
Lal	NULL
ed	NULL
B	NULL
EJ	NULL
3	NULL
=	NULL
87	NULL
E	NULL
p38	NULL
&	NULL
o	NULL
*	NULL
>	NULL
8	NULL
47	NULL
°	NULL
<	NULL
e	NULL
A	NULL
2	NULL
,	NULL
l	NULL
z	NULL
no	NULL
gq	NULL
a	NULL
o	NULL
9	NULL
lel	NULL
9	NULL
a	NULL
te	NULL
ba	NULL
&	NULL
F	NULL
®	NULL
0	NULL
$	NULL
do	NULL
hs	NULL
<	NULL
E	NULL
2	NULL
>	NULL
bat	NULL
<	NULL
2	NULL
@	NULL
5	NULL
i	NULL
a	NULL
C	NULL
fo	NULL
f	NULL
g	NULL
Las	NULL
co	NULL
9	NULL
a	NULL
13	NULL
oo	NULL
FIGURE	NULL
4	NULL
.	NULL

-	NULL
Activation	NULL
of	NULL
p38	NULL
MAPK	NULL
and	NULL
CaMKIV	NULL
by	NULL
CD3	NULL
or	NULL
CD28	NULL
alone	NULL
and	NULL
synergistic	NULL
activation	NULL
by	NULL
CD3/CD28	NULL
.	NULL

A	NULL
,	NULL
EL4	NULL
T	NULL
cells	NULL
were	NULL
stimulated	NULL
with	NULL
anti-CD3	NULL
,	NULL
anti-CD28	NULL
,	NULL
or	NULL
the	NULL
combination	NULL
of	NULL
both	NULL
,	NULL
and	NULL
the	NULL
cell	NULL
extracts	NULL
were	NULL
prepared	NULL
20	NULL
min	NULL
after	NULL
activation	NULL
.	NULL

ERK	NULL
,	NULL
p38	NULL
MAPK	NULL
,	NULL
and	NULL
CaMKIV	NULL
activities	NULL
were	NULL
determined	NULL
as	NULL
described	NULL
in	NULL
Fig	NULL
.	NULL

2C	NULL
.	NULL

B	NULL
,	NULL
Quantita-tion	NULL
of	NULL
the	NULL
results	NULL
obtained	NULL
from	NULL
A	NULL
by	NULL
densitometer	NULL
.	NULL

Numbers	NULL
are	NULL
the	NULL
average	NULL
of	NULL
at	NULL
least	NULL
two	NULL
independent	NULL
kinase	NULL
assays	NULL
.	NULL

6107	NULL
'0t	NULL
4epy	NULL
uo	NULL
1san8	NULL
4q	NULL
[	NULL
810	NULL
fountwrut	NULL
[	NULL
'mmmy	NULL
;	NULL
/	NULL
:	NULL
dyy	NULL
wor	NULL
288	NULL
ERK	NULL
,	NULL
p38	NULL
MAPK	NULL
,	NULL
and	NULL
CaMKIV	NULL
are	NULL
also	NULL
essential	NULL
for	NULL
CD3/	NULL
CD28-induced	NULL
CREB	NULL
Ser'*	NULL
phosphorylation	NULL
133	NULL
Ser	NULL
``	NULL
~	NULL
phosphorylation	NULL
of	NULL
CREB	NULL
is	NULL
the	NULL
primary	NULL
step	NULL
that	NULL
leads	NULL
to	NULL
CBP	NULL
binding	NULL
(	NULL
6-11	NULL
)	NULL
.	NULL

Because	NULL
the	NULL
ERK	NULL
,	NULL
p38	NULL
MAPK	NULL
,	NULL
and	NULL
CaMKIV	NULL
pathways	NULL
mediate	NULL
CREB	NULL
phosphorylation	NULL
induced	NULL
by	NULL
other	NULL
stimuli	NULL
(	NULL
13-20	NULL
)	NULL
,	NULL
we	NULL
further	NULL
examined	NULL
whether	NULL
all	NULL
three	NULL
of	NULL
these	NULL
signaling	NULL
pathways	NULL
were	NULL
involved	NULL
in	NULL
CREB	NULL
phosphorylation	NULL
induced	NULL
by	NULL
CD3/CD28	NULL
.	NULL

Stimulation	NULL
of	NULL
T	NULL
cells	NULL
by	NULL
CD3	NULL
promoted	NULL
the	NULL
Ser'*	NULL
>	NULL
phosphorylation	NULL
of	NULL
CREB	NULL
(	NULL
Fig	NULL
.	NULL

54	NULL
)	NULL
.	NULL

CD3-induced	NULL
phosphorylation	NULL
was	NULL
partially	NULL
inhibited	NULL
by	NULL
PD	NULL
98059	NULL
and	NULL
SB	NULL
203580	NULL
,	NULL
and	NULL
was	NULL
almost	NULL
abolished	NULL
by	NULL
KN-62	NULL
(	NULL
Fig	NULL
.	NULL

5A	NULL
)	NULL
,	NULL
suggesting	NULL
that	NULL
all	NULL
three	NULL
kinase	NULL
cascades	NULL
are	NULL
involved	NULL
in	NULL
CD3-induced	NULL
CREB	NULL
phosphorylation	NULL
.	NULL

CD28	NULL
engagement	NULL
also	NULL
led	NULL
to	NULL
extensive	NULL
CREB	NULL
phosphorylation	NULL
at	NULL
Ser'*	NULL
>	NULL
(	NULL
Fig	NULL
.	NULL

5B	NULL
)	NULL
.	NULL

Consistent	NULL
with	NULL
the	NULL
inability	NULL
of	NULL
CD28	NULL
to	NULL
stimulate	NULL
ERK	NULL
(	NULL
Fig	NULL
.	NULL

4	NULL
)	NULL
,	NULL
CD28-stimulated	NULL
CREB	NULL
phosphorylation	NULL
was	NULL
not	NULL
affected	NULL
by	NULL
PD	NULL
98059	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
CD28-induced	NULL
CREB	NULL
phosphorylation	NULL
was	NULL
suppressed	NULL
by	NULL
SB	NULL
203580	NULL
and	NULL
KN-62	NULL
(	NULL
Fig	NULL
.	NULL

5B	NULL
)	NULL
.	NULL

We	NULL
repeatedly	NULL
observed	NULL
that	NULL
SB	NULL
203580	NULL
(	NULL
10	NULL
uM	NULL
)	NULL
was	NULL
a	NULL
A	NULL
CD3	NULL
-o	NULL
+	NULL
o	NULL
o+	NULL
+	NULL
PD	NULL
-o	NULL
=	NULL
ok	NULL
o-	NULL
o-KN62	NULL
R00	NULL
e	NULL
oe	NULL
o	NULL
$	NULL
o-SB	NULL
=o	NULL
0	NULL
to	NULL
0	NULL
oto	NULL
o	NULL
o-+	NULL
Site	NULL
-	NULL
<	NULL
-	NULL
pCREB	NULL
«	NULL
o	NULL
«	NULL
h	NULL
CL	NULL
an	NULL
wan	NULL
--	NULL
CREB	NULL
B	NULL
CD28	NULL
-o	NULL
oot	NULL
o+	NULL
+	NULL
PD	NULL
-o	NULL
=	NULL
¢	NULL
o-	NULL
o-KN62	NULL
Roe	NULL
e	NULL
of	NULL
SB	NULL
-o	NULL
0	NULL
=	NULL
0	NULL
=	NULL
o-	NULL
o	NULL
o+	NULL
With	NULL
wth	NULL
-	NULL
-=-	NULL
pCREB	NULL
«	NULL
»	NULL
am	NULL
»	NULL
«	NULL
ih	NULL
TD	NULL
UB	NULL
-s	NULL
CREB	NULL
C	NULL
CD3/28	NULL
-	NULL
-+	NULL
+	NULL
+	NULL
PD	NULL
Ro	NULL
=	NULL
ok	NULL
o-	NULL
o-KN62	NULL
-	NULL
-	NULL
-o	NULL
$	NULL
o	NULL
--	NULL
+	NULL
SB	NULL
=o	NULL
_	NULL
``	NULL
~	NULL
Wit	NULL
am	NULL
»	NULL
ase	NULL
«	NULL
am	NULL
--	NULL
pCREB	NULL
«	NULL
w	NULL
»	NULL
«	NULL
Hb	NULL
Hih	NULL
HB	NULL
B	NULL
-s	NULL
CREB	NULL
FIGURE	NULL
5	NULL
.	NULL

Signal	NULL
requirements	NULL
for	NULL
CD3/CD28-induced	NULL
CREB	NULL
phosphorylation	NULL
were	NULL
similar	NULL
to	NULL
those	NULL
for	NULL
CREB-CBP	NULL
binding	NULL
.	NULL

Nuclear	NULL
extracts	NULL
were	NULL
prepared	NULL
1	NULL
h	NULL
after	NULL
anti-CD3/anti-CD28	NULL
treatment	NULL
of	NULL
ELA	NULL
T	NULL
cells	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
the	NULL
inhibitors	NULL
indicated	NULL
.	NULL

The	NULL
concentrations	NULL
of	NULL
the	NULL
inhibitors	NULL
were	NULL
the	NULL
same	NULL
as	NULL
those	NULL
in	NULL
Fig	NULL
.	NULL

2	NULL
.	NULL

Thirty	NULL
micrograms	NULL
of	NULL
each	NULL
extract	NULL
was	NULL
resolved	NULL
by	NULL
10	NULL
%	NULL
SDS-PAGE	NULL
and	NULL
transferred	NULL
to	NULL
a	NULL
polyvinylidene	NULL
difluoride	NULL
membrane	NULL
.	NULL

The	NULL
membrane	NULL
was	NULL
detected	NULL
with	NULL
anti-phosphorylated	NULL
CREB	NULL
(	NULL
Upstate	NULL
Biotechnology	NULL
)	NULL
or	NULL
anti-CREB	NULL
(	NULL
25	NULL
)	NULL
using	NULL
ECL	NULL
reagents	NULL
(	NULL
Amer-sham	NULL
)	NULL
.	NULL

The	NULL
doublet	NULL
of	NULL
CREB	NULL
corresponding	NULL
to	NULL
CREB341	NULL
and	NULL
CREB327	NULL
was	NULL
previously	NULL
reported	NULL
(	NULL
70	NULL
)	NULL
.	NULL

pCREB	NULL
,	NULL
CREB	NULL
phosphorylated	NULL
at	NULL
Ser'*	NULL
>	NULL
.	NULL

CD3/CD28-INDUCED	NULL
CREB-CBP	NULL
INTERACTION	NULL
more	NULL
effective	NULL
inhibitor	NULL
of	NULL
CD28-initiated	NULL
CREB	NULL
phosphorylation	NULL
than	NULL
was	NULL
KN-62	NULL
(	NULL
10	NULL
uM	NULL
)	NULL
.	NULL

CREB	NULL
Ser	NULL
'	NULL
>	NULL
phosphorylation	NULL
was	NULL
increased	NULL
by	NULL
costimulation	NULL
of	NULL
CD3	NULL
and	NULL
CD28	NULL
(	NULL
Fig	NULL
.	NULL

5C	NULL
)	NULL
.	NULL

CD3/CD28-induced	NULL
CREB	NULL
phosphorylation	NULL
was	NULL
equally	NULL
sensitive	NULL
to	NULL
PD	NULL
98059	NULL
,	NULL
KN-62	NULL
,	NULL
and	NULL
SB	NULL
203580	NULL
,	NULL
suggesting	NULL
that	NULL
ERK	NULL
,	NULL
p38	NULL
MAPK	NULL
,	NULL
and	NULL
CaMKIV	NULL
are	NULL
also	NULL
essential	NULL
for	NULL
CD3/CD28-induced	NULL
CREB	NULL
Ser	NULL
'	NULL
``	NULL
>	NULL
phosphorylation	NULL
.	NULL

The	NULL
synergistic	NULL
effect	NULL
of	NULL
CD3	NULL
and	NULL
CD28	NULL
in	NULL
CREB	NULL
phosphorylation	NULL
is	NULL
supported	NULL
by	NULL
the	NULL
fact	NULL
that	NULL
none	NULL
of	NULL
the	NULL
three	NULL
inhibitors	NULL
was	NULL
as	NULL
effective	NULL
as	NULL
in	NULL
the	NULL
inhibition	NULL
of	NULL
CREB	NULL
phosphorylation	NULL
triggered	NULL
by	NULL
sole	NULL
CD3	NULL
or	NULL
CD28	NULL
(	NULL
Fig	NULL
.	NULL

5C	NULL
)	NULL
.	NULL

Synergistic	NULL
effect	NULL
of	NULL
ERK	NULL
,	NULL
p38	NULL
MAPK	NULL
,	NULL
and	NULL
Ca	NULL
``	NULL
*	NULL
on	NULL
CREB-CBP	NULL
interaction	NULL
The	NULL
observed	NULL
signaling	NULL
requirement	NULL
for	NULL
CREB-CBP	NULL
binding	NULL
was	NULL
further	NULL
examined	NULL
by	NULL
reconstitution	NULL
experiments	NULL
.	NULL

ERK	NULL
was	NULL
activated	NULL
through	NULL
expression	NULL
of	NULL
active	NULL
MKK1	NULL
(	NULL
53	NULL
)	NULL
,	NULL
p38	NULL
MAPK	NULL
was	NULL
stimulated	NULL
through	NULL
expression	NULL
of	NULL
active	NULL
MKK3b	NULL
(	NULL
54	NULL
)	NULL
,	NULL
and	NULL
CaMKIV	NULL
was	NULL
activated	NULL
by	NULL
calcium	NULL
ionophore	NULL
A23187	NULL
in	NULL
EL4	NULL
T	NULL
cells	NULL
.	NULL

Kinase	NULL
assay	NULL
confirmed	NULL
the	NULL
activation	NULL
of	NULL
the	NULL
respective	NULL
kinase	NULL
(	NULL
Fig	NULL
.	NULL

6A	NULL
)	NULL
.	NULL

Transfection	NULL
of	NULL
either	NULL
active	NULL
MKK1	NULL
or	NULL
MKK3	NULL
alone	NULL
weakly	NULL
stimulated	NULL
pGAL-CBD	NULL
plus	NULL
pVP16-CREB	NULL
(	NULL
Fig	NULL
.	NULL

6B	NULL
)	NULL
.	NULL

MKK1	NULL
stimulated	NULL
a	NULL
2-fold	NULL
activation	NULL
of	NULL
pG	NULL
,	NULL
B-CAT	NULL
,	NULL
while	NULL
MKK3	NULL
led	NULL
to	NULL
a	NULL
3.6-fold	NULL
activation	NULL
.	NULL

CREB-CBP	NULL
interaction	NULL
was	NULL
increased	NULL
to	NULL
13.8-fold	NULL
when	NULL
stimulated	NULL
by	NULL
a	NULL
combination	NULL
of	NULL
MKK1	NULL
and	NULL
A23187	NULL
.	NULL

Combination	NULL
of	NULL
MKK3	NULL
plus	NULL
A23187	NULL
further	NULL
increased	NULL
the	NULL
binding	NULL
of	NULL
VP16-CREB	NULL
to	NULL
Gal4-CBD	NULL
by	NULL
23.9-fold	NULL
(	NULL
Fig	NULL
.	NULL

6B	NULL
)	NULL
.	NULL

Up	NULL
to	NULL
37-fold	NULL
activation	NULL
of	NULL
pG	NULL
,	NULL
B-CAT	NULL
was	NULL
observed	NULL
when	NULL
it	NULL
was	NULL
stimulated	NULL
by	NULL
a	NULL
combination	NULL
of	NULL
MKK1	NULL
,	NULL
MKK3	NULL
,	NULL
and	NULL
A23187	NULL
,	NULL
indicating	NULL
a	NULL
very	NULL
strong	NULL
CREB-CBP	NULL
interaction	NULL
.	NULL

The	NULL
CREB-CBP	NULL
binding	NULL
stimulated	NULL
by	NULL
reconstitution	NULL
of	NULL
the	NULL
individual	NULL
signals	NULL
was	NULL
similarly	NULL
dependent	NULL
on	NULL
Ser'*	NULL
>	NULL
phosphorylation	NULL
.	NULL

pG	NULL
,	NULL
B-CAT	NULL
was	NULL
no	NULL
longer	NULL
activated	NULL
when	NULL
VP16-CREB	NULL
was	NULL
replaced	NULL
with	NULL
VP16-CREB	NULL
[	NULL
S133A	NULL
]	NULL
(	NULL
Fig	NULL
.	NULL

6C	NULL
)	NULL
.	NULL

We	NULL
also	NULL
tested	NULL
the	NULL
ability	NULL
of	NULL
JNK	NULL
and	NULL
PI	NULL
3-kinase	NULL
,	NULL
two	NULL
kinases	NULL
that	NULL
are	NULL
activated	NULL
by	NULL
CD3/CD28	NULL
,	NULL
to	NULL
promote	NULL
CREB-CBP	NULL
binding	NULL
.	NULL

JNK	NULL
was	NULL
activated	NULL
by	NULL
expression	NULL
of	NULL
active	NULL
MKK7	NULL
,	NULL
as	NULL
indicated	NULL
by	NULL
the	NULL
phosphorylation	NULL
of	NULL
GST	NULL
-c-Jun	NULL
,	NULL
and	NULL
PI	NULL
3-kinase	NULL
was	NULL
activated	NULL
by	NULL
expression	NULL
of	NULL
p110*	NULL
(	NULL
55	NULL
)	NULL
,	NULL
as	NULL
indicated	NULL
by	NULL
the	NULL
phosphorylation	NULL
of	NULL
Akt	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

MKK7	NULL
or	NULL
p110*	NULL
alone	NULL
did	NULL
not	NULL
stimulate	NULL
the	NULL
interaction	NULL
of	NULL
CREB	NULL
and	NULL
CBP	NULL
(	NULL
Fig	NULL
.	NULL

7	NULL
)	NULL
.	NULL

Moreover	NULL
,	NULL
in	NULL
contrast	NULL
to	NULL
the	NULL
effective	NULL
activation	NULL
of	NULL
pG	NULL
,	NULL
B-CAT	NULL
by	NULL
the	NULL
combination	NULL
of	NULL
MKK1	NULL
and	NULL
A23187	NULL
,	NULL
the	NULL
inclusion	NULL
of	NULL
PI	NULL
3-kinase	NULL
or	NULL
MKK7	NULL
in	NULL
the	NULL
stimulation	NULL
cocktail	NULL
did	NULL
not	NULL
add	NULL
to	NULL
the	NULL
interaction	NULL
of	NULL
CREB	NULL
and	NULL
CBP	NULL
.	NULL

Synergistic	NULL
effect	NULL
of	NULL
ERK	NULL
,	NULL
p38	NULL
MAPK	NULL
,	NULL
and	NULL
Ca	NULL
``	NULL
*	NULL
on	NULL
CREB	NULL
trans-activation	NULL
The	NULL
synergistic	NULL
effect	NULL
of	NULL
ERK	NULL
,	NULL
p38	NULL
MAPK	NULL
,	NULL
and	NULL
CaMKIV	NULL
on	NULL
CRE-CAT	NULL
was	NULL
further	NULL
examined	NULL
to	NULL
evaluate	NULL
the	NULL
frans-activation	NULL
of	NULL
CREB	NULL
.	NULL

Similar	NULL
to	NULL
pVP16-CREB/pGAL-CBD	NULL
,	NULL
the	NULL
expression	NULL
of	NULL
CRE-CAT	NULL
was	NULL
weakly	NULL
stimulated	NULL
by	NULL
transfection	NULL
with	NULL
MKK1	NULL
and	NULL
MKK3b	NULL
(	NULL
Fig	NULL
.	NULL

8A	NULL
)	NULL
.	NULL

Expression	NULL
of	NULL
either	NULL
MKK1	NULL
or	NULL
MKK3b	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
A23187	NULL
further	NULL
increased	NULL
the	NULL
activation	NULL
of	NULL
CRE-CAT	NULL
.	NULL

CRE-CAT	NULL
was	NULL
optimally	NULL
activated	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
MKK1	NULL
,	NULL
MKK3	NULL
,	NULL
and	NULL
A123817	NULL
.	NULL

We	NULL
also	NULL
used	NULL
a	NULL
promoter	NULL
of	NULL
PCNA	NULL
,	NULL
in	NULL
which	NULL
the	NULL
activation	NULL
is	NULL
dependent	NULL
on	NULL
the	NULL
binding	NULL
of	NULL
CREB	NULL
to	NULL
its	NULL
CRE	NULL
site	NULL
(	NULL
62	NULL
)	NULL
.	NULL

The	NULL
same	NULL
synergistic	NULL
activation	NULL
by	NULL
ERK	NULL
,	NULL
p38	NULL
MAPK	NULL
,	NULL
and	NULL
CaMKIV	NULL
was	NULL
observed	NULL
with	NULL
PCNA-CAT	NULL
(	NULL
Fig	NULL
.	NULL

8B	NULL
)	NULL
.	NULL

The	NULL
observed	NULL
activation	NULL
was	NULL
CREB	NULL
dependent	NULL
,	NULL
as	NULL
deletion	NULL
of	NULL
the	NULL
CRE	NULL
element	NULL
in	NULL
the	NULL
PCNA	NULL
promoter	NULL
eliminated	NULL
the	NULL
coordinated	NULL
inducibility	NULL
mediated	NULL
by	NULL
ERK	NULL
,	NULL
p38	NULL
MAPK	NULL
,	NULL
and	NULL
CaMKIV	NULL
(	NULL
Fig	NULL
.	NULL

8C	NULL
)	NULL
.	NULL

6107	NULL
'0t	NULL
4epy	NULL
uo	NULL
1san8	NULL
4q	NULL
[	NULL
810	NULL
fountwrut	NULL
[	NULL
'mmmy	NULL
;	NULL
/	NULL
:	NULL
dyy	NULL
wor	NULL
The	NULL
Journal	NULL
of	NULL
Immunology	NULL
A	NULL
ERK	NULL
p38	NULL
CaM	NULL
KIV	NULL
er	NULL
9	NULL
o	NULL
&	NULL
Po	NULL
§	NULL
:	NULL
o	NULL
§	NULL
2	NULL
|	NULL
>	NULL
_	NULL
2	NULL
>	NULL
Z	NULL
A	NULL
<	NULL
MBP	NULL
--	NULL
’	NULL
GST-ATF2®	NULL
<	NULL
>	NULL
B	NULL
50	NULL
F	NULL
+pVP16-CREB	NULL
G	NULL
40	NULL
x	NULL
§	NULL
s	NULL
@	NULL
r	NULL
Pa	NULL
§	NULL
20	NULL
<	NULL
=	NULL
10	NULL
C	NULL
&	NULL
0	NULL
ao	NULL
®	NULL
2	NULL
2	NULL
2	NULL
2	NULL
2	NULL
%	NULL
&	NULL
A	NULL
A	NULL
A	NULL
®	NULL
F	NULL
A	NULL
RA	NULL
®	NULL
RA	NULL
®	NULL
bu	NULL
Go	NULL
ha	NULL
Go	NULL
m	NULL
+o	NULL
tf	NULL
O+	NULL
>	NULL
o	NULL
>	NULL
g	NULL
al	NULL
A	NULL
te	NULL
+	NULL
>	NULL
>	NULL
C	NULL
__	NULL
_	NULL
so	NULL
F	NULL
+pVP16-CREB	NULL
[	NULL
S133A	NULL
]	NULL
<	NULL
&	NULL
-	NULL
40	NULL
7	NULL
8	NULL
30	NULL
3	NULL
Es	NULL
5	NULL
20	NULL
<	NULL
T	NULL
3	NULL
10	NULL
ea	NULL
0	NULL
ao	NULL
``	NULL
®	NULL
2	NULL
2	NULL
2	NULL
2	NULL
2	NULL
A	NULL
&	NULL
R	NULL
A	NULL
A	NULL
®	NULL
l	NULL
&	NULL
RA	NULL
A	NULL
aA	NULL
w	NULL
to	NULL
wa	NULL
to	NULL
I	NULL
+	NULL
+o	NULL
+	NULL
>	NULL
>	NULL
>	NULL
a	NULL
a	NULL
A	NULL
tas	NULL
£	NULL
>	NULL
FIGURE	NULL
6	NULL
.	NULL

Synergistic	NULL
effect	NULL
of	NULL
ERK	NULL
,	NULL
p38	NULL
MAPK	NULL
,	NULL
and	NULL
CaMKIV	NULL
on	NULL
CREB-CBP	NULL
interaction	NULL
.	NULL

A	NULL
,	NULL
Activation	NULL
of	NULL
ERK	NULL
,	NULL
p38	NULL
MAPK	NULL
,	NULL
or	NULL
JNK	NULL
by	NULL
transfection	NULL
with	NULL
active	NULL
kinase	NULL
.	NULL

ELA	NULL
T	NULL
cells	NULL
were	NULL
transfected	NULL
with	NULL
active	NULL
MKK1	NULL
,	NULL
active	NULL
MKK3b	NULL
,	NULL
or	NULL
active	NULL
MKK7	NULL
,	NULL
and	NULL
the	NULL
activation	NULL
of	NULL
the	NULL
respective	NULL
kinase	NULL
was	NULL
determined	NULL
16	NULL
h	NULL
later	NULL
.	NULL

B	NULL
,	NULL
ELA	NULL
T	NULL
cells	NULL
were	NULL
transfected	NULL
with	NULL
pGAL-CBD	NULL
,	NULL
pVP16-CREB	NULL
,	NULL
pG	NULL
,	NULL
B-CAT	NULL
,	NULL
and	NULL
pGreen	NULL
Lantern-1	NULL
in	NULL
the	NULL
absence	NULL
or	NULL
the	NULL
presence	NULL
of	NULL
the	NULL
indicated	NULL
kinase/reagent	NULL
.	NULL

CAT	NULL
activities	NULL
were	NULL
determined	NULL
24	NULL
h	NULL
after	NULL
transfection	NULL
.	NULL

C	NULL
,	NULL
Same	NULL
as	NULL
A	NULL
,	NULL
except	NULL
that	NULL
pVP16-CREB	NULL
was	NULL
replaced	NULL
with	NULL
pVP16-CREB	NULL
[	NULL
S133A	NULL
]	NULL
.	NULL

A	NULL
,	NULL
A23187	NULL
.	NULL

Discussion	NULL
In	NULL
the	NULL
present	NULL
study	NULL
we	NULL
found	NULL
that	NULL
either	NULL
TCR	NULL
(	NULL
CD3	NULL
)	NULL
alone	NULL
or	NULL
CD28	NULL
alone	NULL
induced	NULL
phosphorylation	NULL
of	NULL
CREB	NULL
(	NULL
Fig	NULL
.	NULL

5	NULL
)	NULL
,	NULL
yet	NULL
costimulation	NULL
of	NULL
both	NULL
receptors	NULL
was	NULL
essential	NULL
for	NULL
the	NULL
binding	NULL
of	NULL
CREB	NULL
to	NULL
CBP	NULL
(	NULL
Fig	NULL
.	NULL

1	NULL
)	NULL
.	NULL

In	NULL
addition	NULL
,	NULL
CD3/CD28	NULL
costimulation-induced	NULL
CREB-CBP	NULL
interaction	NULL
involves	NULL
ERK	NULL
,	NULL
p38	NULL
MAPK	NULL
,	NULL
and	NULL
CaMKIV	NULL
.	NULL

The	NULL
inhibition	NULL
of	NULL
any	NULL
single	NULL
kinase	NULL
significantly	NULL
prevented	NULL
CREB-CBP	NULL
binding	NULL
(	NULL
Fig	NULL
.	NULL

2	NULL
)	NULL
.	NULL

Therefore	NULL
,	NULL
signaling	NULL
from	NULL
ERK	NULL
,	NULL
p38	NULL
MAPK	NULL
,	NULL
and	NULL
CaMKIV	NULL
is	NULL
required	NULL
for	NULL
a	NULL
stable	NULL
CREB-CBP	NULL
interaction	NULL
when	NULL
costimulated	NULL
by	NULL
CD3	NULL
and	NULL
CD28	NULL
.	NULL

This	NULL
finding	NULL
was	NULL
supported	NULL
by	NULL
a	NULL
reconstitution	NULL
experiment	NULL
in	NULL
which	NULL
ERK	NULL
,	NULL
p38	NULL
,	NULL
and	NULL
calcium	NULL
signal	NULL
acted	NULL
together	NULL
to	NULL
promote	NULL
strong	NULL
CREB-CBP	NULL
binding	NULL
in	NULL
T	NULL
cells	NULL
(	NULL
Fig	NULL
.	NULL

6B	NULL
)	NULL
.	NULL

Coordination	NULL
of	NULL
these	NULL
three	NULL
signals	NULL
appears	NULL
to	NULL
be	NULL
required	NULL
for	NULL
optimum	NULL
binding	NULL
of	NULL
CREB	NULL
.	NULL

We	NULL
also	NULL
found	NULL
that	NULL
the	NULL
signal	NULL
requirements	NULL
for	NULL
CREB-CBP	NULL
binding	NULL
and	NULL
for	NULL
CRE-CAT	NULL
expression	NULL
were	NULL
nearly	NULL
identical	NULL
(	NULL
Fig	NULL
.	NULL

3	NULL
)	NULL
.	NULL

This	NULL
is	NULL
consistent	NULL
with	NULL
the	NULL
suggestion	NULL
that	NULL
CRE-mediated	NULL
gene	NULL
expression	NULL
are	NULL
activated	NULL
if	NULL
a	NULL
stable	NULL
CREB-CBP	NULL
complex	NULL
can	NULL
be	NULL
formed	NULL
(	NULL
63	NULL
,	NULL
64	NULL
)	NULL
.	NULL

289	NULL
25-+pVP16-CREB	NULL
20	NULL
Fold	NULL
Activation	NULL
V+IMMW	NULL
MEId+TMMW	NULL
V+MEId+TIMMW	NULL
FIGURE	NULL
7	NULL
.	NULL

Inability	NULL
of	NULL
JNK	NULL
and	NULL
PI	NULL
3-kinase	NULL
to	NULL
increase	NULL
CREB-CBP	NULL
binding	NULL
.	NULL

EL4	NULL
T	NULL
cells	NULL
were	NULL
transfected	NULL
with	NULL
pGAL-CBD	NULL
,	NULL
pVP16-CREB	NULL
,	NULL
pG	NULL
,	NULL
B-CAT	NULL
,	NULL
and	NULL
pGreen	NULL
Lantern-1	NULL
in	NULL
the	NULL
absence	NULL
or	NULL
the	NULL
presence	NULL
of	NULL
MKK1	NULL
,	NULL
p110*	NULL
(	NULL
PBK	NULL
)	NULL
,	NULL
MKK7	NULL
,	NULL
A23187	NULL
,	NULL
or	NULL
their	NULL
combinations	NULL
.	NULL

CAT	NULL
activities	NULL
were	NULL
determined	NULL
24	NULL
h	NULL
after	NULL
transfection	NULL
We	NULL
have	NULL
further	NULL
illustrated	NULL
that	NULL
multiple	NULL
signals	NULL
are	NULL
required	NULL
both	NULL
in	NULL
the	NULL
CREB	NULL
Ser'*	NULL
>	NULL
phosphorylation	NULL
step	NULL
(	NULL
Fig	NULL
.	NULL

5	NULL
)	NULL
and	NULL
in	NULL
the	NULL
CREB-CBP	NULL
binding	NULL
stage	NULL
(	NULL
Fig	NULL
.	NULL

2	NULL
)	NULL
stimulated	NULL
by	NULL
CD3/CD28	NULL
.	NULL

ERK	NULL
,	NULL
CaMKIV	NULL
,	NULL
and	NULL
p38	NULL
were	NULL
involved	NULL
in	NULL
CD3-induced	NULL
CREB	NULL
phosphorylation	NULL
,	NULL
with	NULL
a	NULL
higher	NULL
contribution	NULL
from	NULL
CaMKIV	NULL
(	NULL
Fig	NULL
.	NULL

5A	NULL
)	NULL
.	NULL

CaMKIV	NULL
and	NULL
p38	NULL
were	NULL
participated	NULL
in	NULL
CD28-triggered	NULL
phosphorylation	NULL
,	NULL
with	NULL
a	NULL
slightly	NULL
increased	NULL
contribution	NULL
from	NULL
p38	NULL
(	NULL
Fig	NULL
.	NULL

5B	NULL
)	NULL
.	NULL

Costimulation	NULL
of	NULL
CD3	NULL
and	NULL
CD28	NULL
led	NULL
to	NULL
a	NULL
synergistically	NULL
elevated	NULL
CREB	NULL
phosphorylation	NULL
that	NULL
was	NULL
almost	NULL
equally	NULL
dependent	NULL
on	NULL
ERK	NULL
,	NULL
CaMKIV	NULL
,	NULL
and	NULL
p38	NULL
(	NULL
Fig	NULL
.	NULL

5C	NULL
)	NULL
.	NULL

Inhibition	NULL
of	NULL
ERK	NULL
,	NULL
CaMKIV	NULL
,	NULL
and	NULL
p38	NULL
each	NULL
led	NULL
to	NULL
a	NULL
>	NULL
50	NULL
%	NULL
decrease	NULL
in	NULL
CREB	NULL
Ser'*	NULL
>	NULL
phosphorylation	NULL
,	NULL
which	NULL
is	NULL
well	NULL
correlated	NULL
with	NULL
the	NULL
extent	NULL
of	NULL
suppression	NULL
observed	NULL
on	NULL
CREB-CBP	NULL
binding	NULL
by	NULL
PD	NULL
98059	NULL
,	NULL
KN-62	NULL
,	NULL
or	NULL
SB	NULL
203580	NULL
(	NULL
Fig	NULL
.	NULL

24	NULL
)	NULL
.	NULL

A	NULL
full	NULL
CREB	NULL
Ser'*	NULL
>	NULL
phosphorylation	NULL
and	NULL
an	NULL
optimum	NULL
CREB-CBP	NULL
interaction	NULL
in	NULL
T	NULL
cells	NULL
display	NULL
a	NULL
similar	NULL
dependence	NULL
on	NULL
simultaneous	NULL
activation	NULL
of	NULL
ERK	NULL
,	NULL
p38	NULL
,	NULL
and	NULL
CaMKIV	NULL
.	NULL

However	NULL
,	NULL
CREB	NULL
Ser'*	NULL
>	NULL
phosphorylation	NULL
was	NULL
induced	NULL
by	NULL
either	NULL
anti-CD3	NULL
or	NULL
anti-CD28	NULL
alone	NULL
(	NULL
Fig	NULL
.	NULL

5	NULL
)	NULL
,	NULL
yet	NULL
no	NULL
CREB-CBP	NULL
interaction	NULL
was	NULL
detectable	NULL
in	NULL
ELA	NULL
cells	NULL
(	NULL
Fig	NULL
.	NULL

1	NULL
)	NULL
.	NULL

Recent	NULL
studies	NULL
have	NULL
suggested	NULL
that	NULL
the	NULL
frans-activation	NULL
of	NULL
CREB	NULL
may	NULL
involve	NULL
multiple	NULL
stages	NULL
.	NULL

Our	NULL
results	NULL
are	NULL
identical	NULL
with	NULL
the	NULL
report	NULL
that	NULL
anti-CD3	NULL
stimulates	NULL
CREB	NULL
phosphorylation	NULL
,	NULL
but	NULL
not	NULL
CRE-CAT	NULL
in	NULL
Jurkat	NULL
cells	NULL
(	NULL
24	NULL
)	NULL
.	NULL

CREB	NULL
also	NULL
remains	NULL
inactive	NULL
even	NULL
though	NULL
Ser'*	NULL
>	NULL
phosphorylation	NULL
is	NULL
induced	NULL
by	NULL
Ca**	NULL
(	NULL
60	NULL
)	NULL
.	NULL

The	NULL
activation	NULL
of	NULL
CREB	NULL
needs	NULL
an	NULL
additional	NULL
signal	NULL
(	NULL
24	NULL
,	NULL
60	NULL
)	NULL
.	NULL

Therefore	NULL
,	NULL
despite	NULL
the	NULL
early	NULL
illustration	NULL
that	NULL
the	NULL
phosphorylation	NULL
event	NULL
is	NULL
directly	NULL
coupled	NULL
to	NULL
CREB	NULL
transcriptional	NULL
activation	NULL
(	NULL
65	NULL
)	NULL
,	NULL
phosphorylation	NULL
of	NULL
CREB	NULL
at	NULL
Ser'*	NULL
>	NULL
is	NULL
not	NULL
sufficient	NULL
to	NULL
activate	NULL
CRE-dependent	NULL
gene	NULL
expression	NULL
(	NULL
24	NULL
,	NULL
60	NULL
,	NULL
66	NULL
)	NULL
.	NULL

It	NULL
has	NULL
been	NULL
suggested	NULL
that	NULL
CREB-CBP	NULL
interaction	NULL
is	NULL
uncoupled	NULL
from	NULL
CBP	NULL
activation	NULL
.	NULL

The	NULL
second	NULL
signal	NULL
is	NULL
to	NULL
activate	NULL
CBP	NULL
or	NULL
other	NULL
cofactors	NULL
for	NULL
assembly	NULL
of	NULL
complete	NULL
transcriptional	NULL
complexes	NULL
or	NULL
to	NULL
dissociate	NULL
a	NULL
hypothetical	NULL
CBP	NULL
inhibitor	NULL
(	NULL
24	NULL
,	NULL
60	NULL
)	NULL
.	NULL

The	NULL
multiple	NULL
signal	NULL
requirement	NULL
for	NULL
CREB	NULL
activation	NULL
may	NULL
be	NULL
partly	NULL
explained	NULL
by	NULL
the	NULL
fact	NULL
that	NULL
different	NULL
signals	NULL
are	NULL
required	NULL
to	NULL
phosphorylate	NULL
CREB	NULL
and	NULL
to	NULL
activate	NULL
CBP	NULL
.	NULL

Alternatively	NULL
,	NULL
the	NULL
possible	NULL
involvement	NULL
of	NULL
Ser'*	NULL
>	NULL
-independent	NULL
mechanisms	NULL
(	NULL
61	NULL
)	NULL
in	NULL
CD3	NULL
6107	NULL
'0t	NULL
4epy	NULL
uo	NULL
1san8	NULL
4q	NULL
[	NULL
810	NULL
fountwrut	NULL
[	NULL
'mmmy	NULL
;	NULL
/	NULL
:	NULL
dyy	NULL
wor	NULL
290	NULL
A.	NULL
a	NULL
3	NULL
C	NULL
Z	NULL
C	NULL
<	NULL
k=	NULL
©	NULL
(	NULL
S	NULL
Ao	NULL
*	NULL
2	NULL
2	NULL
2	NULL
2	NULL
2	NULL
A	NULL
XA	NULL
XA	NULL
®	NULL
E	NULL
Po	NULL
Eb	NULL
pg	NULL
:	NULL
>	NULL
P	NULL
P	NULL
A	NULL
6	NULL
B.	NULL
z	NULL
10	NULL
PCNA-CAT	NULL
e	NULL
tJ	NULL
]	NULL
&	NULL
A	NULL
6	NULL
<	NULL
S3	NULL
C	NULL
2	NULL
,	NULL
C.	NULL
&	NULL
=	NULL
PCNA	NULL
(	NULL
-CRE	NULL
)	NULL
-CAT	NULL
=	NULL
]	NULL
G	NULL
&	NULL
S	NULL
<	NULL
3	NULL
©	NULL
ca	NULL
3	NULL
2	NULL
2	NULL
aA	NULL
2	NULL
6	NULL
V+IMXW	NULL
V+EMMHN	NULL
FIGURE	NULL
8	NULL
.	NULL

Induction	NULL
of	NULL
CREB-dependent	NULL
expression	NULL
of	NULL
CRE-CAT	NULL
and	NULL
PCNA-CAT	NULL
.	NULL

A	NULL
,	NULL
EL4	NULL
cells	NULL
were	NULL
transfected	NULL
with	NULL
CRE-CAT	NULL
together	NULL
with	NULL
the	NULL
indicated	NULL
kinase/reagent	NULL
as	NULL
described	NULL
in	NULL
Fig	NULL
.	NULL

6	NULL
.	NULL

Cell	NULL
lysates	NULL
were	NULL
prepared	NULL
after	NULL
another	NULL
24	NULL
h	NULL
,	NULL
and	NULL
CAT	NULL
activity	NULL
was	NULL
determined	NULL
.	NULL

B	NULL
,	NULL
ELA	NULL
cells	NULL
were	NULL
transfected	NULL
with	NULL
PCNA-CAT	NULL
(	NULL
5	NULL
ug	NULL
)	NULL
together	NULL
with	NULL
the	NULL
indicated	NULL
ki-nase/reagents	NULL
,	NULL
and	NULL
the	NULL
CAT	NULL
activities	NULL
were	NULL
determined	NULL
.	NULL

C	NULL
,	NULL
EL4	NULL
cells	NULL
were	NULL
transfected	NULL
with	NULL
ZCRE-PCNA-CAT	NULL
(	NULL
5	NULL
ug	NULL
)	NULL
and	NULL
the	NULL
indicated	NULL
kinase	NULL
,	NULL
and	NULL
the	NULL
CAT	NULL
activities	NULL
were	NULL
determined	NULL
.	NULL

CD28-mediated	NULL
CREB	NULL
activation	NULL
needs	NULL
to	NULL
be	NULL
elucidated	NULL
.	NULL

Efforts	NULL
are	NULL
currently	NULL
devoted	NULL
to	NULL
dissect	NULL
these	NULL
events	NULL
.	NULL

CaMKIV	NULL
is	NULL
supposed	NULL
to	NULL
be	NULL
an	NULL
exception	NULL
to	NULL
the	NULL
above	NULL
multisig-nal	NULL
scenario	NULL
for	NULL
CREB	NULL
activation	NULL
.	NULL

CaMKIV	NULL
alone	NULL
not	NULL
only	NULL
phosphorylates	NULL
CREB	NULL
,	NULL
but	NULL
also	NULL
activates	NULL
CBP	NULL
(	NULL
61	NULL
,	NULL
66	NULL
)	NULL
,	NULL
suggesting	NULL
that	NULL
CaMKIV	NULL
alone	NULL
should	NULL
be	NULL
sufficient	NULL
to	NULL
phosphorylate	NULL
CREB	NULL
and	NULL
to	NULL
promote	NULL
CREB-CBP	NULL
binding	NULL
.	NULL

This	NULL
is	NULL
in	NULL
contrast	NULL
to	NULL
our	NULL
observations	NULL
that	NULL
CD3/CD28	NULL
activated	NULL
CaMKIV	NULL
(	NULL
Fig	NULL
.	NULL

44	NULL
)	NULL
,	NULL
yet	NULL
the	NULL
CD3/	NULL
CD28-induced	NULL
CREB-CBP	NULL
interaction	NULL
still	NULL
required	NULL
signaling	NULL
from	NULL
both	NULL
ERK	NULL
and	NULL
p38	NULL
(	NULL
Fig	NULL
.	NULL

2	NULL
)	NULL
.	NULL

We	NULL
speculate	NULL
that	NULL
there	NULL
are	NULL
two	NULL
possible	NULL
causes	NULL
for	NULL
this	NULL
seeming	NULL
discrepancy	NULL
.	NULL

First	NULL
,	NULL
the	NULL
CaMKIV	NULL
CD3/CD28-INDUCED	NULL
CREB-CBP	NULL
INTERACTION	NULL
activated	NULL
by	NULL
CD3/CD28	NULL
may	NULL
not	NULL
reach	NULL
a	NULL
threshold	NULL
for	NULL
full	NULL
phosphorylation	NULL
of	NULL
CREB	NULL
and	NULL
activation	NULL
of	NULL
CBP	NULL
.	NULL

It	NULL
has	NULL
been	NULL
shown	NULL
that	NULL
a	NULL
low	NULL
concentration	NULL
of	NULL
glutamate	NULL
induces	NULL
CREB	NULL
phosphorylation	NULL
in	NULL
neurons	NULL
,	NULL
but	NULL
CREB	NULL
frans-activation	NULL
occurs	NULL
only	NULL
when	NULL
CBP	NULL
is	NULL
also	NULL
activated	NULL
by	NULL
a	NULL
high	NULL
concentration	NULL
of	NULL
glutamate	NULL
(	NULL
65	NULL
)	NULL
.	NULL

Under	NULL
such	NULL
circumstances	NULL
,	NULL
activation	NULL
signals	NULL
from	NULL
the	NULL
ERK	NULL
and	NULL
p38	NULL
MAPK	NULL
pathways	NULL
are	NULL
required	NULL
for	NULL
sufficient	NULL
phosphorylation	NULL
of	NULL
CREB	NULL
and	NULL
formation	NULL
of	NULL
an	NULL
active	NULL
transcription	NULL
complex	NULL
.	NULL

Second	NULL
,	NULL
kinases	NULL
such	NULL
as	NULL
CaMKIV	NULL
are	NULL
regulated	NULL
by	NULL
tightly	NULL
associated	NULL
phos-phatases	NULL
,	NULL
such	NULL
that	NULL
inactivation	NULL
of	NULL
CaMKIV	NULL
occurs	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
sustained	NULL
increases	NULL
in	NULL
Ca**	NULL
``	NULL
(	NULL
67	NULL
)	NULL
.	NULL

Signals	NULL
from	NULL
ERK	NULL
or	NULL
p38	NULL
MAPK	NULL
may	NULL
help	NULL
maintain	NULL
the	NULL
activation	NULL
level	NULL
of	NULL
CaMKIV	NULL
through	NULL
antagonism	NULL
of	NULL
the	NULL
specific	NULL
phosphatases	NULL
.	NULL

Similar	NULL
reasons	NULL
may	NULL
explain	NULL
why	NULL
ERK	NULL
or	NULL
p38	NULL
cascade	NULL
alone	NULL
is	NULL
insufficient	NULL
to	NULL
activate	NULL
CREB	NULL
in	NULL
T	NULL
cells	NULL
stimulated	NULL
through	NULL
CD3/CD28	NULL
,	NULL
even	NULL
though	NULL
a	NULL
weak	NULL
CREB-CBP	NULL
binding	NULL
(	NULL
2-	NULL
to	NULL
3-fold	NULL
)	NULL
was	NULL
detected	NULL
when	NULL
MKK1	NULL
or	NULL
MKK3	NULL
was	NULL
overexpressed	NULL
(	NULL
Figs	NULL
.	NULL

6	NULL
and	NULL
7	NULL
)	NULL
.	NULL

Both	NULL
CBP	NULL
binding	NULL
and	NULL
activation	NULL
of	NULL
CREB	NULL
by	NULL
CD3/CD28	NULL
costimulation	NULL
were	NULL
insensitive	NULL
to	NULL
LY	NULL
294002	NULL
and	NULL
wortmannin	NULL
,	NULL
inhibitors	NULL
of	NULL
PI	NULL
3-kinase	NULL
.	NULL

In	NULL
addition	NULL
,	NULL
PI	NULL
3-kinase	NULL
,	NULL
by	NULL
itself	NULL
or	NULL
in	NULL
combination	NULL
with	NULL
MKK1/A23187	NULL
,	NULL
did	NULL
not	NULL
contribute	NULL
to	NULL
CREB-CBP	NULL
binding	NULL
(	NULL
Fig	NULL
.	NULL

7	NULL
)	NULL
.	NULL

Even	NULL
though	NULL
PI	NULL
3-kinase	NULL
is	NULL
activated	NULL
by	NULL
CD28	NULL
ligation	NULL
(	NULL
33	NULL
,	NULL
34	NULL
)	NULL
,	NULL
and	NULL
PI	NULL
3-kinase	NULL
activates	NULL
Akt	NULL
,	NULL
which	NULL
has	NULL
been	NULL
shown	NULL
to	NULL
phosphorylate	NULL
CREB	NULL
(	NULL
21	NULL
)	NULL
,	NULL
our	NULL
results	NULL
suggest	NULL
that	NULL
CD3/CD28	NULL
costimulation	NULL
of	NULL
CREB	NULL
is	NULL
mediated	NULL
by	NULL
a	NULL
PI	NULL
3-kinase-independent	NULL
pathway	NULL
.	NULL

Similarly	NULL
,	NULL
JNK	NULL
,	NULL
another	NULL
kinase	NULL
activated	NULL
by	NULL
CD3/CD28	NULL
costimulation	NULL
,	NULL
was	NULL
not	NULL
able	NULL
to	NULL
stimulate	NULL
CREB-CBP	NULL
interaction	NULL
(	NULL
Fig	NULL
.	NULL

7	NULL
)	NULL
.	NULL

These	NULL
results	NULL
clearly	NULL
illustrate	NULL
that	NULL
not	NULL
all	NULL
CD28-activated	NULL
signals	NULL
are	NULL
involved	NULL
in	NULL
CREB	NULL
frans-activation	NULL
.	NULL

We	NULL
have	NULL
also	NULL
found	NULL
,	NULL
probably	NULL
for	NULL
the	NULL
first	NULL
time	NULL
,	NULL
that	NULL
CD28	NULL
engagement	NULL
alone	NULL
stimulates	NULL
CaMKIV	NULL
and	NULL
p38	NULL
MAPK	NULL
in	NULL
T	NULL
cells	NULL
(	NULL
Fig	NULL
.	NULL

4	NULL
)	NULL
.	NULL

CD28	NULL
costimulatory	NULL
signal	NULL
has	NULL
been	NULL
defined	NULL
mostly	NULL
for	NULL
its	NULL
convergence	NULL
with	NULL
TCR	NULL
signals	NULL
,	NULL
for	NULL
example	NULL
,	NULL
on	NULL
the	NULL
activation	NULL
of	NULL
JNK	NULL
and	NULL
IB	NULL
kinase	NULL
(	NULL
41	NULL
,	NULL
43	NULL
)	NULL
.	NULL

Few	NULL
activation	NULL
events	NULL
stimulated	NULL
by	NULL
CD28	NULL
ligation	NULL
in	NULL
the	NULL
absence	NULL
of	NULL
CD3	NULL
engagement	NULL
have	NULL
been	NULL
reported	NULL
(	NULL
68	NULL
,	NULL
69	NULL
)	NULL
.	NULL

Together	NULL
with	NULL
the	NULL
activation	NULL
of	NULL
PI	NULL
3-K	NULL
(	NULL
35	NULL
)	NULL
,	NULL
the	NULL
present	NULL
study	NULL
supports	NULL
the	NULL
idea	NULL
that	NULL
CD28	NULL
engagement	NULL
independently	NULL
activates	NULL
selective	NULL
kinase	NULL
pathways	NULL
in	NULL
T	NULL
cells	NULL
.	NULL

Our	NULL
results	NULL
thus	NULL
suggest	NULL
that	NULL
CD28	NULL
contributes	NULL
to	NULL
CREB	NULL
activation	NULL
in	NULL
a	NULL
quantitative	NULL
manner	NULL
rather	NULL
than	NULL
in	NULL
a	NULL
qualitative	NULL
manner	NULL
.	NULL

CD3	NULL
alone	NULL
stimulates	NULL
ERK	NULL
,	NULL
p38	NULL
MAPK	NULL
,	NULL
and	NULL
CaMKIV	NULL
,	NULL
but	NULL
CD3	NULL
alone	NULL
does	NULL
not	NULL
promote	NULL
CREB-CBP	NULL
binding	NULL
(	NULL
Fig	NULL
.	NULL

4	NULL
)	NULL
.	NULL

The	NULL
signals	NULL
activated	NULL
by	NULL
CD28	NULL
costimulation	NULL
that	NULL
lead	NULL
to	NULL
CREB-CBP	NULL
interaction	NULL
are	NULL
p38	NULL
MAPK	NULL
and	NULL
CaMKIV	NULL
,	NULL
kinases	NULL
that	NULL
are	NULL
also	NULL
activated	NULL
by	NULL
CD3	NULL
.	NULL

Therefore	NULL
,	NULL
CD28	NULL
costimulation	NULL
acts	NULL
by	NULL
synergistic	NULL
enhancement	NULL
of	NULL
activation	NULL
signals	NULL
from	NULL
CD3	NULL
.	NULL

In	NULL
such	NULL
a	NULL
model	NULL
,	NULL
signals	NULL
from	NULL
CD3	NULL
engagement	NULL
alone	NULL
do	NULL
not	NULL
reach	NULL
a	NULL
threshold	NULL
sufficient	NULL
to	NULL
activate	NULL
transcription	NULL
factor	NULL
such	NULL
as	NULL
CREB	NULL
.	NULL

Only	NULL
through	NULL
the	NULL
augmentation	NULL
from	NULL
CD28	NULL
costimulation	NULL
are	NULL
T	NULL
cell	NULL
activation	NULL
signals	NULL
sufficient	NULL
to	NULL
trigger	NULL
CREB-CBP	NULL
binding	NULL
.	NULL

We	NULL
are	NULL
in	NULL
the	NULL
progress	NULL
of	NULL
determining	NULL
whether	NULL
other	NULL
T	NULL
cell	NULL
activation	NULL
events	NULL
induced	NULL
by	NULL
CD3/CD28	NULL
costimulation	NULL
may	NULL
be	NULL
mediated	NULL
by	NULL
a	NULL
mechanism	NULL
similar	NULL
to	NULL
the	NULL
one	NULL
that	NULL
activates	NULL
CREB	NULL
.	NULL

Acknowledgments	NULL
We	NULL
thank	NULL
Drs	NULL
.	NULL

Daniel	NULL
Olive	NULL
and	NULL
Jean	NULL
Imbert	NULL
for	NULL
helpful	NULL
discussion	NULL
,	NULL
Dr.	NULL
Nataline	NULL
Ahn	NULL
for	NULL
active	NULL
MKK1	NULL
,	NULL
Dr.	NULL
Jiahuai	NULL
Han	NULL
for	NULL
active	NULL
MKK3b	NULL
and	NULL
MKK7	NULL
,	NULL
Dr.	NULL
Sun-Yu	NULL
Ng	NULL
for	NULL
PCNA-CAT	NULL
,	NULL
Dr.	NULL
Michael	NULL
Karin	NULL
for	NULL
HA-JNK1	NULL
,	NULL
Dr.	NULL
Melanine	NULL
Cobb	NULL
for	NULL
ERK2	NULL
,	NULL
Dr.	NULL
Ruey-Hwa	NULL
Chen	NULL
for	NULL
p110*	NULL
,	NULL
Dr.	NULL
Tse-Hua	NULL
Tam	NULL
for	NULL
anti-JNK1	NULL
Ab	NULL
,	NULL
and	NULL
Dr.	NULL
Mark	NULL
Ptashne	NULL
for	NULL
pG	NULL
&	NULL
B-CAT	NULL
.	NULL

We	NULL
also	NULL
thank	NULL
Douglas	NULL
Platt	NULL
for	NULL
the	NULL
editorial	NULL
correction	NULL
.	NULL

References	NULL
1	NULL
.	NULL

Montiminy	NULL
,	NULL
M.	NULL
1997	NULL
.	NULL

Transcriptional	NULL
regulation	NULL
by	NULL
cyclic	NULL
AMP	NULL
.	NULL

Annu	NULL
.	NULL

Rev	NULL
.	NULL

Biochem	NULL
.	NULL

66:807	NULL
.	NULL

6107	NULL
'0t	NULL
4epy	NULL
uo	NULL
1san8	NULL
4q	NULL
[	NULL
810	NULL
fountwrut	NULL
[	NULL
'mmmy	NULL
;	NULL
/	NULL
:	NULL
dyy	NULL
wor	NULL
The	NULL
Journal	NULL
of	NULL
Immunology	NULL
2	NULL
.	NULL

10	NULL
.	NULL

11	NULL
.	NULL

12	NULL
.	NULL

13	NULL
.	NULL

14	NULL
.	NULL

15	NULL
.	NULL

16	NULL
.	NULL

17	NULL
.	NULL

18	NULL
.	NULL

19	NULL
.	NULL

20	NULL
.	NULL

21	NULL
.	NULL

22	NULL
.	NULL

23	NULL
.	NULL

24	NULL
.	NULL

25	NULL
.	NULL

26	NULL
.	NULL

27	NULL
.	NULL

28	NULL
.	NULL

De	NULL
Cesare	NULL
,	NULL
D.	NULL
,	NULL
G.	NULL
M.	NULL
Fimia	NULL
,	NULL
and	NULL
P.	NULL
Sassone-Corsi	NULL
.	NULL

1999	NULL
.	NULL

Signaling	NULL
routes	NULL
to	NULL
CREM	NULL
and	NULL
CREB	NULL
:	NULL
plasticity	NULL
in	NULL
transcriptional	NULL
activation	NULL
.	NULL

Trends	NULL
Biochem	NULL
.	NULL

Sci	NULL
.	NULL

24:281.	NULL
.	NULL

Shaywitz	NULL
,	NULL
A.	NULL
J.	NULL
,	NULL
and	NULL
M.	NULL
E.	NULL
Greenberg	NULL
.	NULL

1999	NULL
.	NULL

CREB	NULL
:	NULL
a	NULL
stimulus-induced	NULL
tran	NULL
scription	NULL
factor	NULL
activated	NULL
by	NULL
a	NULL
diverse	NULL
array	NULL
of	NULL
extracellular	NULL
signals	NULL
.	NULL

Annu	NULL
.	NULL

Rev	NULL
.	NULL

Biochem	NULL
.	NULL

68:821.	NULL
.	NULL

Hoeffler	NULL
,	NULL
J.	NULL
P.	NULL
,	NULL
T.	NULL
E.	NULL
Meyer	NULL
,	NULL
Y.	NULL
Yun	NULL
,	NULL
J.	NULL
L.	NULL
Jameson	NULL
,	NULL
and	NULL
J.	NULL
F.	NULL
Habener	NULL
.	NULL

1988	NULL
.	NULL

Cyclic	NULL
AMP-responsive	NULL
DNA-binding	NULL
protein	NULL
:	NULL
structure	NULL
based	NULL
on	NULL
a	NULL
cloned	NULL
placental	NULL
cDNA	NULL
.	NULL

Science	NULL
242:1430.	NULL
.	NULL

Yamamoto	NULL
,	NULL
K.	NULL
K.	NULL
,	NULL
G.	NULL
A.	NULL
Gonzalez	NULL
,	NULL
W.	NULL
H.	NULL
Biggs	NULL
III	NULL
,	NULL
and	NULL
M.	NULL
R.	NULL
Montminy	NULL
.	NULL

1988	NULL
.	NULL

Phosphorylation-induced	NULL
binding	NULL
and	NULL
transcriptional	NULL
efficacy	NULL
of	NULL
nuclear	NULL
factor	NULL
CREB	NULL
.	NULL

Nature	NULL
334:494.	NULL
.	NULL

Hagiwara	NULL
,	NULL
M.	NULL
,	NULL
P.	NULL
Brindle	NULL
,	NULL
A.	NULL
Harootunian	NULL
,	NULL
R.	NULL
Armstrong	NULL
,	NULL
J.	NULL
Rivier	NULL
,	NULL
W.	NULL
Vale	NULL
,	NULL
R.	NULL
Tsien	NULL
,	NULL
and	NULL
M.	NULL
R.	NULL
Montiminy	NULL
.	NULL

1993	NULL
.	NULL

Coupling	NULL
of	NULL
hormonal	NULL
stimulation	NULL
and	NULL
transcription	NULL
via	NULL
the	NULL
cyclic	NULL
AMP-responsive	NULL
factor	NULL
CREB	NULL
is	NULL
rate	NULL
limited	NULL
by	NULL
nuclear	NULL
entry	NULL
of	NULL
protein	NULL
kinase	NULL
A.	NULL
Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

13:4852.	NULL
.	NULL

Gonzalez	NULL
,	NULL
G.	NULL
A.	NULL
,	NULL
and	NULL
M.	NULL
R.	NULL
Montminy	NULL
.	NULL

1989	NULL
.	NULL

Cyclic	NULL
AMP-regulated	NULL
stimulates	NULL
somatostatin	NULL
gene	NULL
transcription	NULL
by	NULL
phosphorylation	NULL
of	NULL
CREB	NULL
at	NULL
serine	NULL
133	NULL
.	NULL

Cell	NULL
59:675.	NULL
.	NULL

Chrivia	NULL
,	NULL
J.	NULL
C.	NULL
,	NULL
R.	NULL
P.	NULL
S.	NULL
Kwok	NULL
,	NULL
N.	NULL
Lamb	NULL
,	NULL
M.	NULL
Hagiwara	NULL
,	NULL
M.	NULL
R.	NULL
Montminy	NULL
,	NULL
and	NULL
R.	NULL
H.	NULL
Goodman	NULL
.	NULL

1993	NULL
.	NULL

Phosphorylated	NULL
CREB	NULL
binds	NULL
specifically	NULL
to	NULL
the	NULL
nuclear	NULL
protein	NULL
CBP	NULL
.	NULL

Nature	NULL
365:855.	NULL
.	NULL

Kwok	NULL
,	NULL
R.	NULL
P.	NULL
S.	NULL
,	NULL
J.	NULL
R.	NULL
Lundblad	NULL
,	NULL
J.	NULL
C.	NULL
Chrivia	NULL
,	NULL
J.	NULL
P.	NULL
Richards	NULL
,	NULL
H.	NULL
P.	NULL
Bachinger	NULL
,	NULL
R.	NULL
G.	NULL
Brennan	NULL
,	NULL
S.	NULL
G.	NULL
E.	NULL
Roberts	NULL
,	NULL
M.	NULL
R.	NULL
Green	NULL
,	NULL
and	NULL
R.	NULL
H.	NULL
Goodman	NULL
.	NULL

1994	NULL
.	NULL

Nuclear	NULL
factor	NULL
CBP	NULL
is	NULL
a	NULL
coactivator	NULL
for	NULL
the	NULL
transcription	NULL
factor	NULL
CREB	NULL
.	NULL

Nature	NULL
370:223	NULL
.	NULL

Mestas	NULL
,	NULL
S.	NULL
P.	NULL
,	NULL
and	NULL
K.	NULL
J.	NULL
Lumb	NULL
.	NULL

1999	NULL
.	NULL

Electrostatic	NULL
contribution	NULL
of	NULL
phosphorylation	NULL
to	NULL
the	NULL
stability	NULL
of	NULL
the	NULL
CREB-CBP	NULL
activator-coactivator	NULL
complex	NULL
.	NULL

Nat	NULL
.	NULL

Struct	NULL
.	NULL

Biol	NULL
.	NULL

6:613	NULL
.	NULL

Radhakrishnan	NULL
,	NULL
I	NULL
,	NULL
G.	NULL
C.	NULL
Perez-Alvarado	NULL
,	NULL
D.	NULL
Parker	NULL
,	NULL
H.	NULL
J.	NULL
Dyson	NULL
,	NULL
M.	NULL
R.	NULL
Montminy	NULL
,	NULL
and	NULL
P.	NULL
E.	NULL
Wright	NULL
.	NULL

1999	NULL
.	NULL

Structural	NULL
analyses	NULL
of	NULL
CREB-CBP	NULL
transcriptional	NULL
activator-coactivator	NULL
complexes	NULL
by	NULL
NMR	NULL
spectroscopy	NULL
:	NULL
implications	NULL
for	NULL
mapping	NULL
the	NULL
boundaries	NULL
of	NULL
structural	NULL
domains	NULL
.	NULL

J.	NULL
Mol	NULL
.	NULL

Biol	NULL
.	NULL

287:859	NULL
.	NULL

Arias	NULL
,	NULL
J.	NULL
,	NULL
A.	NULL
S.	NULL
Alberts	NULL
,	NULL
P.	NULL
Brindle	NULL
,	NULL
F.	NULL
X.	NULL
Claret	NULL
,	NULL
T.	NULL
Smeal	NULL
,	NULL
M.	NULL
Karin	NULL
,	NULL
J.	NULL
Feramisco	NULL
,	NULL
and	NULL
M.	NULL
Montminy	NULL
.	NULL

1994	NULL
.	NULL

Activation	NULL
of	NULL
cAMP	NULL
and	NULL
mitogen	NULL
responsive	NULL
genes	NULL
relies	NULL
on	NULL
a	NULL
common	NULL
nuclear	NULL
factor	NULL
.	NULL

Nature	NULL
370:226	NULL
.	NULL

Sun	NULL
,	NULL
P.	NULL
,	NULL
H.	NULL
Enslen	NULL
,	NULL
P.	NULL
S.	NULL
Myung	NULL
,	NULL
and	NULL
R.	NULL
A.	NULL
Maurer	NULL
.	NULL

1994	NULL
.	NULL

Differential	NULL
activation	NULL
of	NULL
CREB	NULL
by	NULL
Ca**/calmodulin-dependent	NULL
protein	NULL
kinases	NULL
type	NULL
II	NULL
and	NULL
type	NULL
IV	NULL
involves	NULL
phosphorylation	NULL
of	NULL
a	NULL
site	NULL
that	NULL
negatively	NULL
regulates	NULL
activity	NULL
.	NULL

Genes	NULL
Dev	NULL
.	NULL

8:2527	NULL
.	NULL

Matthews	NULL
,	NULL
R.	NULL
P.	NULL
,	NULL
C.	NULL
R.	NULL
Guthrie	NULL
,	NULL
L.	NULL
M.	NULL
Wailes	NULL
,	NULL
X.	NULL
Zhao	NULL
,	NULL
A.	NULL
R.	NULL
Means	NULL
,	NULL
and	NULL
G.	NULL
S.	NULL
Knight	NULL
.	NULL

1994	NULL
.	NULL

Calcium/calmodulin-dependent	NULL
protein	NULL
kinase	NULL
types	NULL
II	NULL
and	NULL
IV	NULL
differentially	NULL
regulate	NULL
CREB-dependent	NULL
gene	NULL
expression	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

14	NULL
:	NULL
6107	NULL
.	NULL

Bito	NULL
,	NULL
H.	NULL
,	NULL
K.	NULL
Deisseroth	NULL
,	NULL
and	NULL
R.	NULL
W.	NULL
Tsien	NULL
.	NULL

1996	NULL
.	NULL

CREB	NULL
phosphorylation	NULL
and	NULL
dephosphorylation	NULL
:	NULL
a	NULL
Ca**-	NULL
and	NULL
stimulus	NULL
duration-dependent	NULL
switch	NULL
for	NULL
hip-pocampal	NULL
gene	NULL
expression	NULL
.	NULL

Cell	NULL
87:1203	NULL
.	NULL

Xing	NULL
,	NULL
J.	NULL
,	NULL
D.	NULL
D.	NULL
Ginty	NULL
,	NULL
and	NULL
M.	NULL
E.	NULL
Greenberg	NULL
.	NULL

1996	NULL
.	NULL

Coupling	NULL
of	NULL
the	NULL
RAS-MAPK	NULL
pathway	NULL
to	NULL
gene	NULL
activation	NULL
by	NULL
RSK2	NULL
,	NULL
a	NULL
growth	NULL
factor-regulated	NULL
CREB-kinase	NULL
.	NULL

Science	NULL
273:959	NULL
.	NULL

Xing	NULL
,	NULL
J.	NULL
,	NULL
J.	NULL
M.	NULL
Komnhauser	NULL
,	NULL
Z.	NULL
Xia	NULL
,	NULL
B	NULL
.	NULL

A.	NULL
Thiele	NULL
,	NULL
and	NULL
M.	NULL
E.	NULL
Greenberg	NULL
.	NULL

1998	NULL
.	NULL

Nerve	NULL
growth	NULL
factor	NULL
activates	NULL
extracellular	NULL
signal-regulated	NULL
kinase	NULL
and	NULL
p38	NULL
mitogen-activated	NULL
protein	NULL
kinase	NULL
pathways	NULL
to	NULL
stimulate	NULL
CREB	NULL
serine	NULL
133	NULL
phosphorylation	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

18:1946	NULL
.	NULL

Tan	NULL
,	NULL
Y.	NULL
,	NULL
J	NULL
.	NULL

Rouse	NULL
,	NULL
A.	NULL
Zhang	NULL
,	NULL
S.	NULL
Cariati	NULL
,	NULL
P.	NULL
Cohen	NULL
,	NULL
and	NULL
M.	NULL
J.	NULL
Comb	NULL
.	NULL

1996	NULL
.	NULL

FGF	NULL
and	NULL
stress	NULL
regulate	NULL
CREB	NULL
and	NULL
ATF-1	NULL
via	NULL
a	NULL
pathway	NULL
involving	NULL
p38	NULL
MAP	NULL
kinase	NULL
and	NULL
MAPKAP	NULL
kinase-2	NULL
EMBO	NULL
J	NULL
.	NULL

15:4629	NULL
.	NULL

Deak	NULL
,	NULL
M.	NULL
,	NULL
A.	NULL
D.	NULL
Clifton	NULL
,	NULL
L.	NULL
M.	NULL
Lucocq	NULL
,	NULL
and	NULL
D.	NULL
R.	NULL
Alessi	NULL
.	NULL

1998	NULL
.	NULL

Mitogen-	NULL
and	NULL
stress-activated	NULL
protein	NULL
kinase-	NULL
(	NULL
MSK-1	NULL
)	NULL
is	NULL
directly	NULL
activated	NULL
by	NULL
MAPK	NULL
and	NULL
SAPK2/p38	NULL
,	NULL
and	NULL
may	NULL
mediate	NULL
activation	NULL
of	NULL
CREB	NULL
.	NULL

EMBO	NULL
J	NULL
.	NULL

17:4426	NULL
.	NULL

Pictrat	NULL
,	NULL
B.	NULL
,	NULL
J.	NULL
S.	NULL
Correia	NULL
,	NULL
J.	NULL
L.	NULL
Mary	NULL
,	NULL
M.	NULL
Tomas-Zuber	NULL
,	NULL
and	NULL
W.	NULL
Lesslauer	NULL
.	NULL

1998	NULL
.	NULL

RSK-B	NULL
,	NULL
a	NULL
novel	NULL
ribosomal	NULL
S6	NULL
kinase	NULL
family	NULL
member	NULL
,	NULL
is	NULL
a	NULL
CREB	NULL
kinase	NULL
under	NULL
dominant	NULL
control	NULL
of	NULL
p38	NULL
@	NULL
mitogen-activated	NULL
protein	NULL
kinase	NULL
(	NULL
p38	NULL
MAPK	NULL
)	NULL
.	NULL

J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

273:29661	NULL
.	NULL

Du	NULL
,	NULL
K.	NULL
,	NULL
and	NULL
M.	NULL
Montminy	NULL
.	NULL

1998	NULL
.	NULL

CREB	NULL
is	NULL
a	NULL
regulatory	NULL
target	NULL
for	NULL
the	NULL
protein	NULL
kinase	NULL
Akt/PKB	NULL
.	NULL

J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

273:32377.	NULL
de	NULL
Groot	NULL
,	NULL
R.	NULL
P.	NULL
,	NULL
J.	NULL
den	NULL
Hertog	NULL
,	NULL
J.	NULL
R.	NULL
Vandenheede	NULL
,	NULL
J.	NULL
Goris	NULL
,	NULL
and	NULL
P.	NULL
Sassone-Corsi	NULL
.	NULL

1993	NULL
.	NULL

Multiple	NULL
and	NULL
cooperative	NULL
phosphorylation	NULL
events	NULL
regulate	NULL
the	NULL
CREM	NULL
activator	NULL
function	NULL
.	NULL

EMBO	NULL
J	NULL
.	NULL

12:3903.	NULL
de	NULL
Groot	NULL
,	NULL
R.	NULL
P.	NULL
,	NULL
L.	NULL
M.	NULL
Ballow	NULL
,	NULL
and	NULL
P.	NULL
Sassone-Corsi	NULL
.	NULL

1994	NULL
.	NULL

Positive	NULL
regulation	NULL
of	NULL
the	NULL
cAMP-responsive	NULL
activator	NULL
CREM	NULL
by	NULL
the	NULL
p70	NULL
S6	NULL
kinase	NULL
:	NULL
an	NULL
alternative	NULL
route	NULL
to	NULL
mitogen-induced	NULL
gene	NULL
expression	NULL
.	NULL

Cell	NULL
79:81	NULL
.	NULL

Brindle	NULL
,	NULL
P.	NULL
,	NULL
T.	NULL
Nakajima	NULL
,	NULL
and	NULL
M.	NULL
Montminy	NULL
.	NULL

1995	NULL
.	NULL

Multiple	NULL
protein	NULL
kinase	NULL
A-regulated	NULL
events	NULL
are	NULL
required	NULL
for	NULL
transcriptional	NULL
induction	NULL
by	NULL
cAMP	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
92:10521	NULL
.	NULL

Hsuch	NULL
,	NULL
Y.-P.	NULL
,	NULL
H.-E.	NULL
Liang	NULL
,	NULL
S.-Y	NULL
.	NULL

Ng	NULL
,	NULL
and	NULL
M.-Z	NULL
.	NULL

Lai	NULL
.	NULL

1997	NULL
.	NULL

CD28-costimulation	NULL
activates	NULL
cyclic	NULL
AMP-responsive	NULL
element	NULL
binding	NULL
protein	NULL
in	NULL
T	NULL
lymphocytes	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

158:85	NULL
.	NULL

Barton	NULL
,	NULL
K.	NULL
,	NULL
N.	NULL
Muthusamy	NULL
,	NULL
M.	NULL
Chanyanggam	NULL
,	NULL
C.	NULL
Fischer	NULL
,	NULL
C.	NULL
Cledenin	NULL
,	NULL
and	NULL
J.	NULL
M.	NULL
Leiden	NULL
.	NULL

1996	NULL
.	NULL

Defective	NULL
thymocyte	NULL
proliferation	NULL
and	NULL
IL-2	NULL
production	NULL
in	NULL
transgenic	NULL
mice	NULL
expressing	NULL
a	NULL
dominant-negative	NULL
form	NULL
of	NULL
CREB	NULL
.	NULL

Nature	NULL
379:81	NULL
.	NULL

Anderson	NULL
,	NULL
K.	NULL
A.	NULL
,	NULL
T.	NULL
J.	NULL
Ribar	NULL
,	NULL
M.	NULL
Illario	NULL
,	NULL
and	NULL
A.	NULL
R.	NULL
Means	NULL
.	NULL

1997	NULL
.	NULL

Defective	NULL
survival	NULL
and	NULL
activation	NULL
of	NULL
thymocytes	NULL
in	NULL
transgenic	NULL
mice	NULL
expressing	NULL
a	NULL
catalytic	NULL
inactive	NULL
form	NULL
of	NULL
Ca*	NULL
*	NULL
/calmodulin-dependent	NULL
protein	NULL
kinase	NULL
IV	NULL
.	NULL

Mol	NULL
.	NULL

Endocrinol	NULL
.	NULL

11:725	NULL
.	NULL

Rudolph	NULL
,	NULL
D.	NULL
,	NULL
A.	NULL
Tafuri	NULL
,	NULL
P.	NULL
Gass	NULL
,	NULL
G.	NULL
J.	NULL
Hammerling	NULL
,	NULL
B.	NULL
Arnold	NULL
,	NULL
and	NULL
G.	NULL
Schutz	NULL
.	NULL

1998	NULL
.	NULL

Impaired	NULL
fetal	NULL
T	NULL
cell	NULL
development	NULL
and	NULL
perinatal	NULL
lethality	NULL
in	NULL
mice	NULL
lacking	NULL
the	NULL
cAMP	NULL
response	NULL
element	NULL
binding	NULL
protein	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
95:4481	NULL
.	NULL

29	NULL
.	NULL

30	NULL
.	NULL

31	NULL
.	NULL

32	NULL
.	NULL

33	NULL
.	NULL

34	NULL
.	NULL

35	NULL
.	NULL

36	NULL
.	NULL

37	NULL
.	NULL

38	NULL
.	NULL

39	NULL
.	NULL

40	NULL
.	NULL

41	NULL
.	NULL

42	NULL
.	NULL

43	NULL
.	NULL

45	NULL
.	NULL

46	NULL
.	NULL

47	NULL
.	NULL

48	NULL
.	NULL

49	NULL
.	NULL

50	NULL
.	NULL

51	NULL
.	NULL

52	NULL
.	NULL

53	NULL
.	NULL

54	NULL
.	NULL

55	NULL
.	NULL

56	NULL
.	NULL

57	NULL
.	NULL

58	NULL
.	NULL

291	NULL
Belkowski	NULL
,	NULL
S.	NULL
M.	NULL
,	NULL
C.	NULL
S.	NULL
Rubin	NULL
,	NULL
and	NULL
M.	NULL
B.	NULL
Prystowsky	NULL
.	NULL

1998	NULL
.	NULL

Isolation	NULL
and	NULL
analysis	NULL
of	NULL
a	NULL
T	NULL
cell	NULL
clone	NULL
variant	NULL
exhibiting	NULL
constitutively	NULL
phosphorylated	NULL
Ser'**	NULL
cAMP	NULL
responsive	NULL
element-binding	NULL
protein	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

161:659	NULL
.	NULL

Zhang	NULL
,	NULL
F.	NULL
,	NULL
D.-Z	NULL
.	NULL

Wang	NULL
,	NULL
M.	NULL
Boothby	NULL
,	NULL
L.	NULL
Penix	NULL
,	NULL
R.	NULL
A.	NULL
Flavell	NULL
,	NULL
and	NULL
T.	NULL
M.	NULL
Aune	NULL
.	NULL

1998	NULL
.	NULL

Regulation	NULL
of	NULL
the	NULL
activity	NULL
of	NULL
IFN-y	NULL
promoter	NULL
elements	NULL
during	NULL
Th	NULL
cell	NULL
differentiation	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

161:6105	NULL
.	NULL

Lenschow	NULL
,	NULL
D.	NULL
J.	NULL
,	NULL
T.	NULL
L.	NULL
Walunas	NULL
,	NULL
and	NULL
J	NULL
.	NULL

A.	NULL
Bluestone	NULL
.	NULL

1996	NULL
.	NULL

CD28/B7	NULL
system	NULL
of	NULL
T	NULL
cell	NULL
costimulation	NULL
.	NULL

Annu	NULL
.	NULL

Rev	NULL
.	NULL

Immunol	NULL
.	NULL

14:233	NULL
.	NULL

Chambers	NULL
,	NULL
C.	NULL
A.	NULL
,	NULL
and	NULL
J.	NULL
P.	NULL
Allison	NULL
.	NULL

1999	NULL
.	NULL

Costimulatory	NULL
regulation	NULL
of	NULL
T	NULL
cell	NULL
function	NULL
.	NULL

Curr	NULL
.	NULL

Opin	NULL
.	NULL

Cell	NULL
Biol	NULL
.	NULL

11:203	NULL
.	NULL

Harding	NULL
,	NULL
F.	NULL
A.	NULL
,	NULL
J.	NULL
G.	NULL
McArthur	NULL
,	NULL
J	NULL
.	NULL

A	NULL
.	NULL

Gross	NULL
,	NULL
D.	NULL
H.	NULL
Raulet	NULL
,	NULL
and	NULL
J.	NULL
P.	NULL
Allison	NULL
.	NULL

1992	NULL
.	NULL

CD28-mediated	NULL
signalling	NULL
co-stimulates	NULL
murine	NULL
T	NULL
cells	NULL
and	NULL
prevents	NULL
induction	NULL
of	NULL
anergy	NULL
in	NULL
T-cell	NULL
clones	NULL
.	NULL

Nature	NULL
356:607	NULL
.	NULL

Boise	NULL
,	NULL
L.	NULL
H.	NULL
,	NULL
A.	NULL
J.	NULL
Minn	NULL
,	NULL
P.	NULL
J.	NULL
Noel	NULL
,	NULL
C.	NULL
H.	NULL
June	NULL
,	NULL
M.	NULL
A.	NULL
Accavitti	NULL
,	NULL
T.	NULL
Lindsten	NULL
,	NULL
and	NULL
C.	NULL
B.	NULL
Thompson	NULL
.	NULL

1995	NULL
.	NULL

CD28	NULL
costimulation	NULL
can	NULL
promote	NULL
T	NULL
cell	NULL
survival	NULL
by	NULL
enhancing	NULL
the	NULL
expression	NULL
of	NULL
Bcl-X	NULL
;	NULL
,	NULL
.	NULL

Immunity	NULL
3:87	NULL
.	NULL

Pages	NULL
,	NULL
F.	NULL
,	NULL
M.	NULL
Ragueneau	NULL
,	NULL
R.	NULL
Rottapel	NULL
,	NULL
A.	NULL
Trunch	NULL
,	NULL
J.	NULL
Nunes	NULL
,	NULL
J.	NULL
Imbert	NULL
,	NULL
and	NULL
D.	NULL
Olive	NULL
.	NULL

1994	NULL
.	NULL

Binding	NULL
of	NULL
phosphatidylinositol-3-OH	NULL
kinase	NULL
to	NULL
CD28	NULL
is	NULL
required	NULL
for	NULL
T-cell	NULL
signalling	NULL
.	NULL

Nature	NULL
369:327	NULL
.	NULL

Truitt	NULL
,	NULL
K.	NULL
E.	NULL
,	NULL
C.	NULL
M.	NULL
Hicks	NULL
,	NULL
and	NULL
J	NULL
.	NULL

B.	NULL
Imboden	NULL
.	NULL

1994	NULL
.	NULL

Stimulation	NULL
of	NULL
CD28	NULL
triggers	NULL
an	NULL
association	NULL
between	NULL
CD28	NULL
and	NULL
phosphatidylinositol	NULL
3-kinase	NULL
in	NULL
Jurkat	NULL
T	NULL
cells	NULL
.	NULL

J.	NULL
Exp	NULL
.	NULL

Med	NULL
.	NULL

179:1071	NULL
.	NULL

Prasad	NULL
,	NULL
K.	NULL
V.	NULL
S.	NULL
,	NULL
Y.-C.	NULL
Cai	NULL
,	NULL
M.	NULL
Raab	NULL
,	NULL
B.	NULL
Duckworth	NULL
,	NULL
L.	NULL
Cantely	NULL
,	NULL
S.	NULL
E.	NULL
Shoelson	NULL
,	NULL
and	NULL
C.	NULL
E.	NULL
Rudd	NULL
.	NULL

1994	NULL
.	NULL

T	NULL
cell	NULL
antigen	NULL
CD28	NULL
interacts	NULL
with	NULL
the	NULL
lipid	NULL
kinase	NULL
phosphatidylinositol	NULL
3-kinase	NULL
by	NULL
a	NULL
cytoplasmic	NULL
Tyr	NULL
(	NULL
P	NULL
)	NULL
-Met-Xaa-Met	NULL
motif	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
91:2834	NULL
.	NULL

Hutchcroft	NULL
,	NULL
J.	NULL
E.	NULL
,	NULL
D.	NULL
P.	NULL
Franklin	NULL
,	NULL
B.	NULL
Tsai	NULL
,	NULL
D.	NULL
Harrison-Findik	NULL
,	NULL
L.	NULL
Varticovski	NULL
,	NULL
and	NULL
B.	NULL
E.	NULL
Bieber	NULL
.	NULL

1995	NULL
.	NULL

Phorbol	NULL
ester	NULL
treatment	NULL
inhibits	NULL
phosphatidylinositol	NULL
3-kinase	NULL
activation	NULL
by	NULL
,	NULL
and	NULL
association	NULL
with	NULL
,	NULL
CD28	NULL
,	NULL
a	NULL
T-lymphocyte	NULL
surface	NULL
receptor	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
92:8808	NULL
.	NULL

Crooks	NULL
,	NULL
M.	NULL
E.	NULL
C.	NULL
,	NULL
D.	NULL
R.	NULL
Littman	NULL
,	NULL
R.	NULL
H.	NULL
Carter	NULL
,	NULL
D.	NULL
T.	NULL
Fearson	NULL
,	NULL
A.	NULL
Weiss	NULL
,	NULL
and	NULL
P.	NULL
H.	NULL
Stein	NULL
.	NULL

1995	NULL
.	NULL

CD28-mediated	NULL
costimulation	NULL
in	NULL
the	NULL
absence	NULL
of	NULL
phosphatidylinositol	NULL
3-kinase	NULL
association	NULL
and	NULL
activation	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

15:6820	NULL
.	NULL

Truitt	NULL
,	NULL
K.	NULL
E.	NULL
,	NULL
J.	NULL
Shi	NULL
,	NULL
S.	NULL
Gibson	NULL
,	NULL
L.	NULL
G.	NULL
Segal	NULL
,	NULL
G.	NULL
B	NULL
.	NULL

Mills	NULL
,	NULL
and	NULL
J	NULL
.	NULL

B.	NULL
Imboden	NULL
.	NULL

1995	NULL
.	NULL

CD28	NULL
delivers	NULL
costimulatory	NULL
signals	NULL
independently	NULL
of	NULL
its	NULL
association	NULL
with	NULL
phosphatidylinositol	NULL
3-kinase	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

155:4702	NULL
.	NULL

Su	NULL
,	NULL
B.	NULL
,	NULL
E.	NULL
Jacinto	NULL
,	NULL
M.	NULL
Hibi	NULL
,	NULL
T.	NULL
Kallunki	NULL
,	NULL
M.	NULL
Karin	NULL
,	NULL
and	NULL
Y.	NULL
Ben-Nerian	NULL
.	NULL

1994	NULL
.	NULL

JNK	NULL
is	NULL
involved	NULL
in	NULL
the	NULL
signal	NULL
integration	NULL
during	NULL
costimulation	NULL
of	NULL
T	NULL
lymphocytes	NULL
.	NULL

Cell	NULL
77:727	NULL
.	NULL

Barz	NULL
,	NULL
C.	NULL
,	NULL
T.	NULL
Nagel	NULL
,	NULL
K.	NULL
E.	NULL
Truitt	NULL
,	NULL
and	NULL
J	NULL
.	NULL

B.	NULL
Imboden	NULL
.	NULL

1998	NULL
.	NULL

Mutational	NULL
analysis	NULL
of	NULL
CD28-mediated	NULL
costimulation	NULL
of	NULL
Jun-N-terminal	NULL
kinase	NULL
and	NULL
IL-2	NULL
production	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

161:5366	NULL
.	NULL

Harhaj	NULL
,	NULL
E.	NULL
W.	NULL
,	NULL
and	NULL
S.-C.	NULL
Sun	NULL
.	NULL

1998	NULL
.	NULL

IB	NULL
kinases	NULL
serve	NULL
as	NULL
a	NULL
target	NULL
of	NULL
CD28	NULL
signaling	NULL
.	NULL

J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

273:25185.	NULL
.	NULL

Matsuda	NULL
,	NULL
S.	NULL
,	NULL
T.	NULL
Moriguchi	NULL
,	NULL
S.	NULL
Koyasu	NULL
,	NULL
and	NULL
E.	NULL
Nishida	NULL
.	NULL

1998	NULL
.	NULL

T	NULL
lymphocyte	NULL
activation	NULL
signal	NULL
for	NULL
interleukin-2	NULL
production	NULL
involve	NULL
activation	NULL
of	NULL
MKK6-p38	NULL
and	NULL
MKK7-SAPK-JNK	NULL
signaling	NULL
pathways	NULL
sensitive	NULL
to	NULL
cyclosporin	NULL
A.	NULL
J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

273:12378	NULL
.	NULL

Hsu	NULL
,	NULL
S.-C.	NULL
,	NULL
M.	NULL
Gavrilin	NULL
,	NULL
M.-H.	NULL
Tsai	NULL
,	NULL
J.	NULL
Han	NULL
,	NULL
and	NULL
M.-Z	NULL
.	NULL

Lai	NULL
.	NULL

1999.	NULL
p38	NULL
mitogen	NULL
activated	NULL
protein	NULL
kinase	NULL
is	NULL
involved	NULL
in	NULL
Fas	NULL
ligand	NULL
expression	NULL
.	NULL

J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

274:25769	NULL
.	NULL

Zhang	NULL
,	NULL
J.	NULL
,	NULL
K.	NULL
V.	NULL
Salojin	NULL
,	NULL
J.-X	NULL
.	NULL

Gao	NULL
,	NULL
M.	NULL
J.	NULL
Cameron	NULL
,	NULL
I.	NULL
Bergerot	NULL
,	NULL
and	NULL
T.	NULL
Delovitch	NULL
.	NULL

1999.	NULL
p38	NULL
mitogen-activated	NULL
protein	NULL
kinase	NULL
mediates	NULL
signal	NULL
integration	NULL
of	NULL
TCR/	NULL
CD28	NULL
costimulation	NULL
in	NULL
primary	NULL
murine	NULL
T	NULL
cells	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

162:3819	NULL
.	NULL

Li	NULL
,	NULL
L.	NULL
,	NULL
C.	NULL
Yee	NULL
,	NULL
and	NULL
J	NULL
.	NULL

A.	NULL
Beavo	NULL
.	NULL

1999	NULL
.	NULL

CD3-	NULL
and	NULL
CD28-dependent	NULL
induction	NULL
of	NULL
PDE7	NULL
required	NULL
for	NULL
T	NULL
cell	NULL
activation	NULL
.	NULL

Science	NULL
283:848	NULL
.	NULL

Hsueh	NULL
,	NULL
Y.-P.	NULL
,	NULL
and	NULL
M.-Z	NULL
.	NULL

Lai	NULL
.	NULL

1995	NULL
.	NULL

Overexpression	NULL
of	NULL
activation	NULL
transcriptional	NULL
factor	NULL
1	NULL
in	NULL
lymphomas	NULL
and	NULL
in	NULL
activated	NULL
lymphocytes	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

154:5675	NULL
.	NULL

Gross	NULL
,	NULL
J	NULL
.	NULL

A.	NULL
,	NULL
E.	NULL
Callas	NULL
,	NULL
and	NULL
J.	NULL
P.	NULL
Allison	NULL
.	NULL

1992	NULL
.	NULL

Identification	NULL
and	NULL
distribution	NULL
of	NULL
the	NULL
costimulatory	NULL
receptor	NULL
CD28	NULL
in	NULL
the	NULL
mouse	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

149:380	NULL
.	NULL

Shih	NULL
,	NULL
H.	NULL
,	NULL
P.	NULL
Goldman	NULL
,	NULL
A.	NULL
J.	NULL
DeMaggio	NULL
,	NULL
S.	NULL
M.	NULL
Hollenberg	NULL
,	NULL
R.	NULL
H.	NULL
Goodman	NULL
,	NULL
and	NULL
M.	NULL
F.	NULL
Hoesktra	NULL
.	NULL

1996	NULL
.	NULL

A	NULL
positive	NULL
genetic	NULL
selection	NULL
for	NULL
disrupting	NULL
protein-protein	NULL
interactions	NULL
:	NULL
identification	NULL
of	NULL
CREB	NULL
mutations	NULL
that	NULL
prevent	NULL
association	NULL
with	NULL
coactivator	NULL
CBP	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
93:13896	NULL
.	NULL

Sadowski	NULL
,	NULL
L.	NULL
,	NULL
J.	NULL
Ma	NULL
,	NULL
S.	NULL
Triezenberg	NULL
,	NULL
and	NULL
M.	NULL
Ptashne	NULL
.	NULL

1988	NULL
.	NULL

GAL4-VP16	NULL
is	NULL
an	NULL
unusually	NULL
potent	NULL
transcriptional	NULL
activator	NULL
.	NULL

Nature	NULL
335:563	NULL
.	NULL

Lee	NULL
,	NULL
H.-H.	NULL
,	NULL
W.-H.	NULL
Chiang	NULL
,	NULL
S.-H.	NULL
Chaing	NULL
,	NULL
Y.-C.	NULL
Liu	NULL
,	NULL
J.	NULL
Huang	NULL
,	NULL
and	NULL
S.-Y	NULL
.	NULL

Ng	NULL
.	NULL

1995	NULL
.	NULL

Regulation	NULL
of	NULL
cyclin	NULL
D1	NULL
,	NULL
DNA	NULL
topoisomerase	NULL
I	NULL
,	NULL
and	NULL
proliferating	NULL
cell	NULL
nuclear	NULL
antigen	NULL
promoters	NULL
during	NULL
the	NULL
cell	NULL
cycle	NULL
.	NULL

Gene	NULL
Expression	NULL
4:95	NULL
.	NULL

Mansour	NULL
,	NULL
S.	NULL
J.	NULL
,	NULL
W.	NULL
T.	NULL
Matten	NULL
,	NULL
A.	NULL
S.	NULL
Hermann	NULL
,	NULL
J.	NULL
M.	NULL
Candia	NULL
,	NULL
S.	NULL
Rong	NULL
,	NULL
K.	NULL
Fukasawa	NULL
,	NULL
G.	NULL
F.	NULL
Vande	NULL
Woude	NULL
,	NULL
and	NULL
N.	NULL
G.	NULL
Ahn	NULL
.	NULL

1994	NULL
.	NULL

Transformation	NULL
of	NULL
mammalian	NULL
cells	NULL
by	NULL
constitutively	NULL
active	NULL
MAP	NULL
kinase	NULL
kinase	NULL
.	NULL

Science	NULL
265:966	NULL
.	NULL

Jiang	NULL
,	NULL
Y.	NULL
,	NULL
C.	NULL
Chen	NULL
,	NULL
Z.	NULL
Li	NULL
,	NULL
W.	NULL
Guo	NULL
,	NULL
J	NULL
.	NULL

A.	NULL
Gegner	NULL
,	NULL
S.	NULL
Lin	NULL
,	NULL
and	NULL
J.	NULL
Han	NULL
.	NULL

1996	NULL
.	NULL

Characterization	NULL
of	NULL
the	NULL
structure	NULL
and	NULL
function	NULL
of	NULL
a	NULL
new	NULL
mitogen-activated	NULL
protein	NULL
kinase	NULL
(	NULL
p38B	NULL
)	NULL
.	NULL

J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

271:17920	NULL
.	NULL

Klippel	NULL
,	NULL
A.	NULL
,	NULL
C.	NULL
Reinhard	NULL
,	NULL
W.	NULL
M.	NULL
Kavanaugh	NULL
,	NULL
G.	NULL
Apell	NULL
,	NULL
M.-A	NULL
.	NULL

Escobedo	NULL
,	NULL
and	NULL
L.	NULL
T.	NULL
Williams	NULL
.	NULL

1996	NULL
.	NULL

Membrane	NULL
localization	NULL
of	NULL
phosphatidylinositol	NULL
3-kinase	NULL
is	NULL
sufficient	NULL
to	NULL
activate	NULL
multiple	NULL
signal-transduction	NULL
kinase	NULL
pathways	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

16:4117	NULL
.	NULL

Ho	NULL
,	NULL
H.-Y	NULL
.	NULL

,	NULL
H.-H.	NULL
Lee	NULL
,	NULL
and	NULL
M.-Z	NULL
.	NULL

Lai	NULL
.	NULL

1997	NULL
.	NULL

Overexpression	NULL
of	NULL
mitogen-activated	NULL
protein	NULL
kinase	NULL
kinase	NULL
kinase	NULL
reversed	NULL
cAMP	NULL
inhibition	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
in	NULL
T	NULL
cells	NULL
.	NULL

Eur	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

27:222	NULL
.	NULL

Hsueh	NULL
,	NULL
Y.-P.	NULL
,	NULL
and	NULL
M.-Z	NULL
.	NULL

Lai	NULL
.	NULL

1995	NULL
.	NULL

JNK	NULL
but	NULL
not	NULL
MAP	NULL
kinase	NULL
is	NULL
sensitive	NULL
to	NULL
cAMP	NULL
in	NULL
T	NULL
lymphocytes	NULL
.	NULL

J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

270:18094	NULL
.	NULL

Meyer	NULL
,	NULL
C.	NULL
F.	NULL
,	NULL
X.	NULL
Wang	NULL
,	NULL
C.	NULL
Chang	NULL
,	NULL
D.	NULL
Templeton	NULL
,	NULL
and	NULL
T.-H.	NULL
Tan	NULL
.	NULL

1996	NULL
.	NULL

Interaction	NULL
between	NULL
c-Rel	NULL
and	NULL
the	NULL
mitogen-activated	NULL
protein	NULL
kinase	NULL
kinase	NULL
kinase	NULL
1	NULL
signaling	NULL
cascade	NULL
in	NULL
mediating	NULL
B	NULL
enhancer	NULL
activation	NULL
.	NULL

J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

271:8971	NULL
.	NULL

6107	NULL
'0t	NULL
4epy	NULL
uo	NULL
1san8	NULL
4q	NULL
[	NULL
810	NULL
fountwrut	NULL
[	NULL
'mmmy	NULL
;	NULL
/	NULL
:	NULL
dyy	NULL
wor	NULL
292	NULL
59	NULL
.	NULL

60	NULL
.	NULL

61	NULL
.	NULL

62	NULL
.	NULL

63	NULL
.	NULL

Jiang	NULL
,	NULL
Y.	NULL
,	NULL
H.	NULL
Gram	NULL
,	NULL
M.	NULL
Zhao	NULL
,	NULL
L.	NULL
New	NULL
,	NULL
J.	NULL
Gu	NULL
,	NULL
L.	NULL
Feng	NULL
,	NULL
F.	NULL
D.	NULL
Padova	NULL
,	NULL
R.	NULL
J.	NULL
Ulevitch	NULL
,	NULL
and	NULL
J.	NULL
Han	NULL
.	NULL

1997	NULL
.	NULL

Characterization	NULL
of	NULL
the	NULL
structure	NULL
and	NULL
function	NULL
of	NULL
the	NULL
fourth	NULL
member	NULL
of	NULL
p38	NULL
group	NULL
mitogen-activated	NULL
protein	NULL
kinases	NULL
,	NULL
p38	NULL
.	NULL

J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

272:30122	NULL
.	NULL

Thompson	NULL
,	NULL
M.	NULL
A.	NULL
,	NULL
D.	NULL
D.	NULL
Ginty	NULL
,	NULL
A.	NULL
Bonni	NULL
,	NULL
and	NULL
M.	NULL
E.	NULL
Greenberg	NULL
.	NULL

1995	NULL
.	NULL

L-type	NULL
voltage-sensitive	NULL
Ca	NULL
channel	NULL
activation	NULL
regulates	NULL
c-fos	NULL
transcription	NULL
at	NULL
multiple	NULL
level	NULL
.	NULL

J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

270:4224	NULL
.	NULL

Chawla	NULL
,	NULL
S.	NULL
,	NULL
G.	NULL
E.	NULL
Hardingham	NULL
,	NULL
D.	NULL
R.	NULL
Quinn	NULL
,	NULL
and	NULL
H.	NULL
Bading	NULL
.	NULL

1998	NULL
.	NULL

CBP	NULL
:	NULL
a	NULL
signal-regulated	NULL
transcriptional	NULL
coactivator	NULL
controlled	NULL
by	NULL
nuclear	NULL
calcium	NULL
and	NULL
CaM	NULL
kinase	NULL
IV	NULL
.	NULL

Science	NULL
281:1505	NULL
.	NULL

Huang	NULL
,	NULL
D.	NULL
,	NULL
P.	NULL
M.	NULL
Shipman-Appasamy	NULL
,	NULL
D.	NULL
J.	NULL
Orten	NULL
,	NULL
S.	NULL
H.	NULL
Hinrich	NULL
,	NULL
and	NULL
M.	NULL
B.	NULL
Prystowsky	NULL
.	NULL

1994	NULL
.	NULL

Promoter	NULL
activity	NULL
of	NULL
the	NULL
proliferating-cell	NULL
nuclear	NULL
antigen	NULL
gene	NULL
is	NULL
associated	NULL
with	NULL
inducible	NULL
CRE-binding	NULL
proteins	NULL
in	NULL
interleukin	NULL
2-stimulated	NULL
T	NULL
lymphocytes	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

14:4233	NULL
.	NULL

Cardinaux	NULL
,	NULL
J.-R.	NULL
,	NULL
J.	NULL
C.	NULL
Notis	NULL
,	NULL
O.	NULL
Zhang	NULL
,	NULL
N.	NULL
Vo	NULL
,	NULL
J.	NULL
C.	NULL
Craig	NULL
,	NULL
D.	NULL
M.	NULL
Fass	NULL
,	NULL
R.	NULL
G.	NULL
Brennan	NULL
,	NULL
and	NULL
R.	NULL
H.	NULL
Goodman	NULL
.	NULL

2000	NULL
.	NULL

Recruitment	NULL
of	NULL
CREB	NULL
binding	NULL
protein	NULL
is	NULL
sufficient	NULL
for	NULL
CREB-mediated	NULL
gene	NULL
activation	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

20:1546.	NULL
.	NULL

Goodman	NULL
,	NULL
R.	NULL
H.	NULL
,	NULL
and	NULL
S.	NULL
Smolik	NULL
.	NULL

2000	NULL
.	NULL

CBP/p300	NULL
in	NULL
cell	NULL
growth	NULL
,	NULL
transformation	NULL
,	NULL
and	NULL
development	NULL
.	NULL

Genes	NULL
Dev	NULL
.	NULL

14:1553	NULL
.	NULL

65	NULL
.	NULL

66	NULL
.	NULL

67	NULL
.	NULL

68	NULL
.	NULL

69	NULL
.	NULL

70	NULL
.	NULL

CD3/CD28-INDUCED	NULL
CREB-CBP	NULL
INTERACTION	NULL
Alberts	NULL
,	NULL
A.	NULL
S.	NULL
,	NULL
J.	NULL
Arias	NULL
,	NULL
M.	NULL
Hagiwara	NULL
,	NULL
M.	NULL
R.	NULL
Montminy	NULL
,	NULL
and	NULL
J.	NULL
R.	NULL
Feramisco	NULL
.	NULL

1994	NULL
.	NULL

Recombinant	NULL
cyclic	NULL
AMP	NULL
response	NULL
element	NULL
binding	NULL
protein	NULL
(	NULL
CREB	NULL
)	NULL
phosphorylated	NULL
on	NULL
Ser-133	NULL
is	NULL
transcriptionally	NULL
active	NULL
upon	NULL
its	NULL
introduction	NULL
into	NULL
fibroblast	NULL
nuclei	NULL
.	NULL

J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

269:7623	NULL
.	NULL

Hu	NULL
,	NULL
S.-C.	NULL
,	NULL
J.	NULL
Chrivia	NULL
,	NULL
and	NULL
A.	NULL
Ghosh	NULL
.	NULL

1999	NULL
.	NULL

Regulation	NULL
of	NULL
CBP-mediated	NULL
transcription	NULL
by	NULL
neuronal	NULL
calcium	NULL
signaling	NULL
.	NULL

Newron	NULL
22:799	NULL
.	NULL

Westphal	NULL
,	NULL
R.	NULL
S.	NULL
,	NULL
K.	NULL
A.	NULL
Anderson	NULL
,	NULL
A.	NULL
R.	NULL
Means	NULL
,	NULL
and	NULL
B.	NULL
E.	NULL
Wadzinski	NULL
.	NULL

1998	NULL
.	NULL

A	NULL
signal	NULL
complex	NULL
of	NULL
Ca**-calmodulin-dependent	NULL
protein	NULL
kinase	NULL
IV	NULL
and	NULL
protein	NULL
phosphatase	NULL
2A	NULL
.	NULL

Science	NULL
280:1258	NULL
.	NULL

Ledbetter	NULL
,	NULL
J	NULL
.	NULL

A.	NULL
,	NULL
J	NULL
.	NULL

B.	NULL
Imboden	NULL
,	NULL
G.	NULL
L.	NULL
Schieven	NULL
,	NULL
L.	NULL
S.	NULL
Grosmaire	NULL
,	NULL
P.	NULL
S.	NULL
Rabinovitch	NULL
,	NULL
T.	NULL
Lindsten	NULL
,	NULL
C.	NULL
B.	NULL
Thompson	NULL
,	NULL
and	NULL
C.	NULL
H.	NULL
June	NULL
.	NULL

1990	NULL
.	NULL

CD28	NULL
ligation	NULL
in	NULL
T-cell	NULL
activation	NULL
:	NULL
evidence	NULL
for	NULL
two	NULL
signal	NULL
transduction	NULL
pathways	NULL
.	NULL

Blood	NULL
75:1531	NULL
.	NULL

Sicfken	NULL
,	NULL
R.	NULL
,	NULL
S.	NULL
Klein-Hefling	NULL
,	NULL
E.	NULL
Serfling	NULL
,	NULL
R.	NULL
Kurrle	NULL
,	NULL
and	NULL
R.	NULL
Schwinzer	NULL
.	NULL

1998	NULL
.	NULL

A	NULL
CD28-associated	NULL
signaling	NULL
pathway	NULL
leading	NULL
to	NULL
cytokine	NULL
gene	NULL
transcription	NULL
and	NULL
T	NULL
cell	NULL
proliferation	NULL
without	NULL
TCR	NULL
engagement	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

161:1645	NULL
.	NULL

Berkowtiz	NULL
,	NULL
L.	NULL
A.	NULL
,	NULL
and	NULL
M.	NULL
Z.	NULL
Gilman	NULL
.	NULL

1990	NULL
.	NULL

Two	NULL
distinct	NULL
forms	NULL
of	NULL
active	NULL
transcriptional	NULL
factor	NULL
CREB	NULL
(	NULL
cAMP	NULL
responsive	NULL
element	NULL
binding	NULL
protein	NULL
}	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
87:5258	NULL
.	NULL

6107	NULL
'0t	NULL
4epy	NULL
uo	NULL
1san8	NULL
4q	NULL
[	NULL
810	NULL
fountwrut	NULL
[	NULL
'mmmy	NULL
;	NULL
/	NULL
:	NULL
dyy	NULL
wor	NULL

